[{"status": "Ongoing", "city": "Bengaluru", "state": "N/A", "country": "India", "classification": "Class II", "openfda": {"application_number": ["ANDA209101"], "brand_name": ["HALOPERIDOL DECANOATE"], "generic_name": ["HALOPERIDOL DECANOATE"], "manufacturer_name": ["BluePoint Laboratories"], "product_ndc": ["68001-578", "68001-579", "68001-580", "68001-581", "68001-582"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR"], "substance_name": ["HALOPERIDOL DECANOATE"], "rxcui": ["859871", "1719803", "1719862"], "spl_id": ["048557ea-f859-f0f2-e063-6294a90af5ab"], "spl_set_id": ["f2d14406-2ad4-4c5b-9c24-a026f27b415d"], "package_ndc": ["68001-579-59", "68001-579-48", "68001-580-41", "68001-581-41", "68001-581-48", "68001-581-82", "68001-578-59", "68001-578-48", "68001-582-41"], "is_original_packager": [true], "upc": ["0368001578592", "0368001581417", "0368001579599", "0368001582414"], "unii": ["AC20PJ4101"]}, "product_type": "Drugs", "event_id": "96569", "recalling_firm": "Somerset Therapeutics Private Limited", "address_1": "54/1 Budihal Village", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0356-2025", "product_description": "Haloperidol Decanoate Injection 50mg/mL, 1mL Single-Dose Vial, Rx Only, Manufactured by: Somerset Therapeutics Limited, Kamataka India, Manufactured for: BluePoint Laboratories NDC 68001-580-41", "product_quantity": "4956 vials", "reason_for_recall": "Lack of Assurance of Sterility: Media fill with bacterial contamination", "recall_initiation_date": "20250321", "center_classification_date": "20250408", "report_date": "20250416", "code_info": "A240467B, exp. date 07/2026"}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA078427"], "brand_name": ["CETIRIZINE HCL"], "generic_name": ["CETIRIZINE"], "manufacturer_name": ["GLENMARK THERAPEUTICS INC., USA"], "product_ndc": ["72657-128", "72657-129", "72657-130", "72657-131"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["CETIRIZINE HYDROCHLORIDE"], "rxcui": ["1014676", "1014678"], "spl_id": ["9b19f466-3796-44b8-a637-092926c275f1"], "spl_set_id": ["04b08c52-5390-4cdb-a9e7-fca81fffdc73"], "package_ndc": ["72657-128-30", "72657-128-45", "72657-128-60", "72657-128-70", "72657-128-90", "72657-128-08", "72657-128-14", "72657-128-15", "72657-128-18", "72657-128-24", "72657-128-03", "72657-128-35", "72657-128-04", "72657-128-81", "72657-128-82", "72657-128-84", "72657-128-86", "72657-128-41", "72657-129-30", "72657-129-45", "72657-129-60", "72657-129-70", "72657-129-90", "72657-129-08", "72657-129-14", "72657-129-15", "72657-129-18", "72657-129-24", "72657-129-03", "72657-129-35", "72657-129-04", "72657-129-81", "72657-129-82", "72657-129-84", "72657-129-86", "72657-129-41", "72657-130-05", "72657-131-89"], "is_original_packager": [true], "upc": ["0372657128353", "0372657129350"], "unii": ["64O047KTOA"]}, "product_type": "Drugs", "event_id": "96474", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0348-2025", "product_description": "Cetirizine Hydrochloride Tablets, USP, 10mg, 365-count packs, Rx Only, Manufactured for: Glenmark Therapeutics Inc., Distributed by: Amazon. NDC# 72657-129-35", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20250313", "center_classification_date": "20250408", "report_date": "20250416", "code_info": "Lot #  17231980, ep.. date Aug-25 Amazon 17232044, ep.. date Aug-25 Walmart  17241436, ep.. date Jul-26 Amazon 17241437, ep.. date Jul-26 Amazon 17241455, ep.. date Jul-26 Amazon 17241456, ep.. date Aug-26 Amazon 17241457, ep.. date Aug-26 Amazon 17241892, ep.. date Oct-26 Amazon 17241893, ep.. date Oct-26 Amazon"}, {"status": "Ongoing", "city": "Ta. Kadi, District Mehsana", "state": "N/A", "country": "India", "classification": "Class II", "openfda": {"application_number": ["M021"], "brand_name": ["NATURE MINT ANTICAVITY"], "generic_name": ["SODIUM MONOFLUOROPHOSPHATE"], "manufacturer_name": ["Bob Barker Company Inc."], "product_ndc": ["53247-131"], "product_type": ["HUMAN OTC DRUG"], "route": ["DENTAL"], "substance_name": ["SODIUM MONOFLUOROPHOSPHATE"], "rxcui": ["545626"], "spl_id": ["25cae217-37ed-403c-8a97-acfae13ef681"], "spl_set_id": ["39e9c844-d2c2-4e3c-84c0-bdb767a03f7b"], "package_ndc": ["53247-131-01", "53247-131-02", "53247-131-03", "53247-131-04", "53247-131-05", "53247-131-06", "53247-131-07"], "is_original_packager": [true], "unii": ["C810JCZ56Q"]}, "product_type": "Drugs", "event_id": "96797", "recalling_firm": "KENIL HEALTHCARE PRIVATE LIMITED", "address_1": "Plot 319", "address_2": "Village Acharasan, Ankhol-Vamaj Road", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "DE and NC", "recall_number": "D-0438-2025", "product_description": "Nature Mint Anticavity Fluoride Toothpaste, Sodium monofluorophosphate 0.76%, NET WT 0.85 OZ (24 grams) Tube, Made in India, Dist. by Bob Barker Co. Inc., Fuquay-Varina, NC 27526, NDC 53247-131-03", "product_quantity": "616,160 Tubes", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20250424", "center_classification_date": "20250519", "report_date": "20250528", "code_info": "Lot B0014, B0015, B0022, B0023, Exp Date: 05/31/2026; Lot B0024, B0025, B0026, B0027, B0033, B0034, B0035, B0039, B0040, B0041, B0045, Exp Date: 06/30/2026; Lot B0046, Exp Date: 07/31/2026"}, {"status": "Ongoing", "city": "Foster City", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA208341"], "brand_name": ["SOFOSBUVIR AND VELPATASVIR"], "generic_name": ["VELPATASVIR AND SOFOSBUVIR"], "manufacturer_name": ["Asegua Therapeutics LLC"], "product_ndc": ["72626-2701"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["SOFOSBUVIR", "VELPATASVIR"], "rxcui": ["1799212"], "spl_id": ["314b9ef7-c6e5-44c9-9fbf-b0d35a24cd7d"], "spl_set_id": ["d0c1a945-4440-4b5c-81aa-693ed3db597c"], "package_ndc": ["72626-2701-1"], "is_original_packager": [true], "nui": ["N0000191493", "N0000191258", "N0000191256", "N0000190113", "N0000185503", "N0000190107", "N0000190108", "N0000190109"], "pharm_class_epc": ["Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC]", "Hepatitis C Virus NS5A Inhibitor [EPC]"], "pharm_class_moa": ["RNA Replicase Inhibitors [MoA]", "Breast Cancer Resistance Protein Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]", "Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]", "Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]", "Organic Anion Transporting Polypeptide 2B1 Inhibitors [MoA]"], "unii": ["WJ6CA3ZU8B", "KCU0C7RS7Z"]}, "product_type": "Drugs", "event_id": "96434", "recalling_firm": "ASEGUA THERAPEUTICS LLC", "address_1": "333 Lakeside Dr", "address_2": "N/A", "postal_code": "94404-1147", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "US Nationwide", "recall_number": "D-0313-2025", "product_description": "Sofosbuvir and Velpatasvir, 400 mg/100 mg tablets, 28 tablets: 2x14 blister cards, Rx Only, Manufactured for: Asegua Therapeutics LLC an affiliate of Gilead Sciences, Inc., Foster City, CA 94404, Made in Ireland, NDC# 72626-2701-1", "product_quantity": "18,541 cartons.", "reason_for_recall": "Defective Container: blister packs not properly sealed resulting in tablets being loose in the carton.", "recall_initiation_date": "20250307", "center_classification_date": "20250407", "report_date": "20250416", "code_info": "Lot# 24ASV002UA, Exp Date: 6/30/2028"}, {"status": "Ongoing", "city": "Dawsonville", "state": "GA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96573", "recalling_firm": "Direct Rx", "address_1": "94 Worldwide Dr", "address_2": "", "postal_code": "30534-6828", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Physicians and medical facilities in 5 states: AL, CA, FL, GA, ID", "recall_number": "D-0364-2025", "product_description": "CIPROFLOXACIN OPHTH SOLUTION, 0.3% 5mL bottle, Rx Only, Generic for CILOXAN, Packaged and Distributed by: DIRECT Rx, NDC 61919-795-05.", "product_quantity": "477 bottles.", "reason_for_recall": "Defective Container: Unable to get the solution out of the bottle as the spike of the cap was lodged in the nozzle of the product bottle", "recall_initiation_date": "20250131", "center_classification_date": "20250415", "report_date": "20250423", "code_info": "Lot 11SE2402, Exp Date: 11/30/2025 Lot 14NO2406, Exp Date: 12/31/2025 Lot 29OC2420, Exp Date: 11/30/2025 Lot 30SE2412, Exp Date: 11/30/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA211082"], "brand_name": ["RANOLAZINE"], "generic_name": ["RANOLAZINE"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "product_ndc": ["68462-319", "68462-320"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["RANOLAZINE"], "rxcui": ["616749", "728231"], "spl_id": ["8872581f-53be-4bde-8d22-c6960f11e9d6"], "spl_set_id": ["0cf58732-c242-49b0-8e3f-248778b4458d"], "package_ndc": ["68462-319-60", "68462-319-05", "68462-320-60", "68462-320-05"], "is_original_packager": [true], "upc": ["0368462320600", "0368462319604"], "nui": ["N0000175427", "N0000190114", "N0000185503", "N0000182137", "N0000187061"], "pharm_class_epc": ["Anti-anginal [EPC]"], "pharm_class_moa": ["Cytochrome P450 3A Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]", "Cytochrome P450 2D6 Inhibitors [MoA]", "Organic Cation Transporter 2 Inhibitors [MoA]"], "unii": ["A6IEZ5M406"]}, "product_type": "Drugs", "event_id": "96474", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0335-2025", "product_description": "Ranolazine  Extended-Release Tablets  1000mg, 60-count bottle, Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh 454775, India, Manufactured for: Glenmark Pharmaceuticals Inc. USA, Mahwah, NJ 07430. NDC# 68462-320-60", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20250313", "center_classification_date": "20250408", "report_date": "20250416", "code_info": "Lot #  17240040, exp. date Dec-25"}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA077987"], "brand_name": ["PRAVASTATIN SODIUM"], "generic_name": ["PRAVASTATIN SODIUM"], "manufacturer_name": ["NorthStar RxLLC"], "product_ndc": ["16714-558", "16714-559", "16714-560", "16714-570"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["PRAVASTATIN SODIUM"], "rxcui": ["904458", "904467", "904475", "904481"], "spl_id": ["fa078b35-ee9d-4b9f-bb8d-e77949c09f88"], "spl_set_id": ["ce15ad07-3286-478f-9f30-1db6a45ed402"], "package_ndc": ["16714-558-01", "16714-558-02", "16714-559-01", "16714-559-02", "16714-560-01", "16714-560-02", "16714-570-01", "16714-570-02"], "is_original_packager": [true], "upc": ["0316714570013", "0316714559018", "0316714560014"], "unii": ["3M8608UQ61"]}, "product_type": "Drugs", "event_id": "96474", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0350-2025", "product_description": "Pravastatin Sodium Tablets, USP, 80mg, a).90-count bottle (16714-570-01), b). 500-count bottle (NDC 16714-570-02), Rx Only, Mfd for: Northstar Rx LLC, Memphis, TN 38141, Mfd by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh 454775, India", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20250313", "center_classification_date": "20250408", "report_date": "20250416", "code_info": "Lot #  17221770, exp. date Aug-25 17221774, exp. date Aug-25 17231251, exp. date May-26 17231262, exp. date May-26 17232112, exp. date Sep-26 17232133, exp. date Sep-26"}, {"status": "Ongoing", "city": "Libertyville", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA201991"], "brand_name": ["METFORMIN HYDROCHLORIDE"], "generic_name": ["METFORMIN HYDROCHLORIDE"], "manufacturer_name": ["A-S Medication Solutions"], "product_ndc": ["50090-1494"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["METFORMIN HYDROCHLORIDE"], "rxcui": ["860975"], "spl_id": ["c83706bb-e844-4e62-b4f4-c48536ea707d"], "spl_set_id": ["0cd086d6-3ae2-476e-b93e-29055e67e8fc"], "package_ndc": ["50090-1494-3", "50090-1494-4", "50090-1494-0", "50090-1494-1", "50090-1494-2"], "original_packager_product_ndc": ["67877-159"], "unii": ["786Z46389E"]}, "product_type": "Drugs", "event_id": "96313", "recalling_firm": "A-S Medication Solutions LLC", "address_1": "2401 Commerce Dr", "address_2": "N/A", "postal_code": "60048-4464", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in U.S.", "recall_number": "D-0292-2025", "product_description": "METFORMIN HYDROCHLORIDE EXTENDED- RELEASE 500MG, 180 TABLETS, Packaged BY: A-S Medication Solutions, Libertyville, IL 60048 NDC 50090-1494-3.", "product_quantity": "411 180-count bottles", "reason_for_recall": "Presence of Foreign Tablets/Capsules.", "recall_initiation_date": "20250225", "center_classification_date": "20250321", "report_date": "20250402", "code_info": "Lot# 4260340; Exp.12/31/2025."}, {"status": "Ongoing", "city": "Zagreb", "state": "N/A", "country": "Croatia", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96601", "recalling_firm": "Apipharma", "address_1": "Ulica Jeronima Kavanjina 26", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "AZ", "recall_number": "D-0375-2025", "product_description": "Hemopropin Ointment, Lanolin 17.76% and Petrolatum 71.2%, Net Wt. 0.7 oz (20g) tubes, Manufactured by: Apipharma d.o.o, Croatia, Distributed by: Apipharma, LLC, Tempe, AZ  UPC 3 858882 103534 and UPC 3 858882 101318", "product_quantity": "4,218 boxes", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20250409", "center_classification_date": "20250418", "report_date": "20250430", "code_info": "Lot #: A00001, Exp.: 2027-12; A00005, Exp.: 2027-01; B00001, Exp.:2028-02"}, {"status": "Ongoing", "city": "Nogales", "state": "AZ", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "96914", "recalling_firm": "Umary-USA.com", "address_1": "243 W Crawford St", "address_2": "STE 40026", "postal_code": "85621-3208", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S. Nationwide via internet.", "recall_number": "D-0492-2025", "product_description": "UNAVY ACIDO HIALURONICO, Conenido: 30 capletas de 850mg, distribuido por: EREN NATURAL S.A. DE C.V, Zappan, Jal. C.P, UPC 7 503046 054295", "product_quantity": "1,342 30-count bottles", "reason_for_recall": "Marketed without approved NDA/ANDA- Laboratory analysis found product to be tainted with undeclared ingredients: Dexamethasone, Diclofenac and Omeprazole.", "recall_initiation_date": "20250521", "center_classification_date": "20250624", "report_date": "20250625", "code_info": "All Lots; All Expiration Dates.", "more_code_info": ""}, {"status": "Ongoing", "city": "Raleigh", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA212399"], "brand_name": ["LEVOTHYROXINE SODIUM"], "generic_name": ["LEVOTHYROXINE SODIUM"], "manufacturer_name": ["Accord Healthcare Inc."], "product_ndc": ["16729-447", "16729-458", "16729-448", "16729-449", "16729-451", "16729-450", "16729-452", "16729-453", "16729-454", "16729-455", "16729-456", "16729-457"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LEVOTHYROXINE SODIUM"], "rxcui": ["892246", "892251", "892255", "966220", "966221", "966222", "966224", "966225", "966248", "966249", "966253", "966270"], "spl_id": ["415fc774-31a5-124f-e063-6294a90a0e46"], "spl_set_id": ["a6233381-3043-4e9a-aaa6-a6b105e5142b"], "package_ndc": ["16729-458-15", "16729-458-17", "16729-447-15", "16729-447-17", "16729-448-15", "16729-448-17", "16729-449-15", "16729-449-17", "16729-451-15", "16729-451-17", "16729-450-15", "16729-450-17", "16729-452-15", "16729-452-17", "16729-453-15", "16729-453-17", "16729-454-15", "16729-454-17", "16729-455-15", "16729-455-17", "16729-456-15", "16729-456-17", "16729-457-15", "16729-457-17"], "is_original_packager": [true], "upc": ["0316729447157", "0316729449151", "0316729452151", "0316729454155", "0316729453158", "0316729448154", "0316729451154", "0316729457156", "0316729450157", "0316729456159", "0316729458153", "0316729455152"], "unii": ["9J765S329G"]}, "product_type": "Drugs", "event_id": "96666", "recalling_firm": "ACCORD HEALTHCARE, INC.", "address_1": "8041 Arco Corporate Dr Ste 200", "address_2": "N/A", "postal_code": "27617-2010", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide US.", "recall_number": "D-0396-2025", "product_description": "Levothyroxine Sodium Tablets, USP, 88 mcg (0.088 mg), 1000 bottles, Rx Only, Manufactured for Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, INDIA, NDC 16729-450-17", "product_quantity": "4,885 Bottles", "reason_for_recall": "Subpotent", "recall_initiation_date": "20250410", "center_classification_date": "20250430", "report_date": "20250507", "code_info": "Lot # D2300044, Exp Date: 12/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Oxnard", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96763", "recalling_firm": "Siddha Flower Essences, LLC.", "address_1": "2350 Eastman Ave Ste 107", "address_2": "N/A", "postal_code": "93030-7265", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "US Nationwide.", "recall_number": "D-0410-2025", "product_description": "temper tamer, 1 US fl oz. (29.6 mL), Homeopathic Oral Spray, Manufactured by: Siddha Flower Essences, Oxnard, CA, 93030  NDC 69779-020-01.", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20250428", "center_classification_date": "20250506", "report_date": "20250514", "code_info": "Lot#  S22-26424D; Exp 9/27/2027", "more_code_info": ""}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA078251"], "brand_name": ["CARVEDILOL"], "generic_name": ["CARVEDILOL"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "product_ndc": ["68462-162", "68462-163", "68462-164", "68462-165"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CARVEDILOL"], "rxcui": ["200031", "200032", "200033", "686924"], "spl_id": ["5f5b2d20-cc2a-4e91-b2b9-260e7438ab2c"], "spl_set_id": ["c4a21f67-7812-4634-beba-f8e85c63c5f2"], "package_ndc": ["68462-162-60", "68462-162-01", "68462-162-18", "68462-162-05", "68462-162-10", "68462-163-60", "68462-163-01", "68462-163-18", "68462-163-05", "68462-163-10", "68462-164-60", "68462-164-01", "68462-164-18", "68462-164-05", "68462-164-10", "68462-165-60", "68462-165-01", "68462-165-18", "68462-165-05", "68462-165-10"], "is_original_packager": [true], "upc": ["0368462162019", "0368462163016", "0368462164013", "0368462165010"], "nui": ["N0000000099", "N0000009923", "N0000009924", "N0000175553", "N0000175556"], "pharm_class_moa": ["Adrenergic alpha-Antagonists [MoA]", "Adrenergic beta1-Antagonists [MoA]", "Adrenergic beta2-Antagonists [MoA]"], "pharm_class_epc": ["alpha-Adrenergic Blocker [EPC]", "beta-Adrenergic Blocker [EPC]"], "unii": ["0K47UL67F2"]}, "product_type": "Drugs", "event_id": "96861", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0451-2025", "product_description": "Carvedilol Tablets USP 25 mg, 500 -Count bottle, Rx Only, Manufactured by: Glenmark Pharmaceuticals Ltd., Manufactured for Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ 07430. NDC 68462-165-05.", "product_quantity": "18,696 bottles", "reason_for_recall": "CGMP Deviations; presence 'N-Nitroso Carvedilol I' Impurity above the recommended acceptable intake limit", "recall_initiation_date": "20250228", "center_classification_date": "20250528", "report_date": "20250604", "code_info": "Lot, expiry: Lots 19231107, 19231114, 19231152, Exp Feb-25; Lot 19234866, Exp Jan-26"}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA205566"], "brand_name": ["FENOFIBRATE"], "generic_name": ["FENOFIBRATE"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "product_ndc": ["68462-580", "68462-581", "68462-582"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["FENOFIBRATE"], "rxcui": ["200311", "310288", "310289"], "spl_id": ["65523b48-95b4-4491-94cc-5c3c79ac41a8"], "spl_set_id": ["e7204052-02cf-4b38-835b-d8754c74b2cd"], "package_ndc": ["68462-580-01", "68462-581-01", "68462-582-01"], "is_original_packager": [true], "upc": ["0368462581018", "0368462580011", "0368462582015"], "nui": ["N0000175596", "N0000175375", "M0199111"], "pharm_class_epc": ["Peroxisome Proliferator Receptor alpha Agonist [EPC]"], "pharm_class_moa": ["Peroxisome Proliferator-activated Receptor alpha Agonists [MoA]"], "pharm_class_cs": ["PPAR alpha [CS]"], "unii": ["U202363UOS"]}, "product_type": "Drugs", "event_id": "96474", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0314-2025", "product_description": "Fenofibrate Capsules 67 mg, USP, 100-count bottle, Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh 454775, India, Manufactured for: Glenmark Pharmaceuticals Inc. USA, Mahwah, NJ 07430. NDC# 68462-580-01", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20250313", "center_classification_date": "20250408", "report_date": "20250416", "code_info": "Lot #  17230834, exp. date Mar-25 17230835, exp. date Mar-25"}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA204730"], "brand_name": ["FROVATRIPTAN SUCCINATE"], "generic_name": ["FROVATRIPTAN SUCCINATE"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "product_ndc": ["68462-694"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["FROVATRIPTAN SUCCINATE"], "rxcui": ["349462"], "spl_id": ["49e68dd9-06c7-4d54-afa9-9016ae0b6995"], "spl_set_id": ["03a58215-dba7-4f63-8b98-d74d054a574a"], "package_ndc": ["68462-694-97"], "is_original_packager": [true], "upc": ["0368462694978"], "unii": ["D28J6W18HY"]}, "product_type": "Drugs", "event_id": "96474", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0322-2025", "product_description": "Frovatriptan Succinate Tablets 2.5mg, 9-count bottle, Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh 454775, India, Manufactured for: Glenmark Pharmaceuticals Inc. USA, Mahwah, NJ 07430. NDC# 68462-694-97", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20250313", "center_classification_date": "20250408", "report_date": "20250416", "code_info": "Lot #  17231352, exp. date Jun-25 17231649, exp. date Jul-25"}, {"status": "Ongoing", "city": "Sugar Land", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96446", "recalling_firm": "QuVa Pharma, Inc.", "address_1": "1075 W Park One Dr Ste 100", "address_2": "N/A", "postal_code": "77478-2576", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0296-2025", "product_description": "fentaNYL Citrate PF 200 mcg/100 mL (2 mcg/ml) /0.125% Bupivacaine HCl 125 mg/100 mL (1.25 mg/mL), 100 ml in NS Yellow CADD FSFF, Injection for Epidural Use (Not intended For IV Use), Compounded, For Institutional or Office Use Only, QuVa Pharma, 1075 West Park One Drive, Suite 100, Sugar Land, Tx 77478. NDC: 70092-1255-75", "product_quantity": "2,310 cassettes", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20250306", "center_classification_date": "20250325", "report_date": "20250402", "code_info": "Lot, expiry:  Lots 10140284, 10140285, 10140315, 10140316, exp 04/08/2025; Lot 10140510, exp 04/14/2025; Lot 10140916, exp 04/24/2025"}, {"status": "Ongoing", "city": "Englewood", "state": "CO", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96607", "recalling_firm": "Denver Solutions, LLC DBA Leiters Health", "address_1": "13796 Compark Blvd", "address_2": "N/A", "postal_code": "80112-7145", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the U.S.A", "recall_number": "D-0374-2025", "product_description": "Rocuronium Bromide 50 mg per 5mL (10mg per mL),  5mL Single Dose Syringe, Rx only, Leiters Health, 13796 Compark Blvd, Englewood, CO 80112. NDC: 71449-004-11", "product_quantity": "16,655 syringes", "reason_for_recall": "Lack of Assurance of Sterility: Leaking/damaged syringes.", "recall_initiation_date": "20250331", "center_classification_date": "20250418", "report_date": "20250430", "code_info": "Lot #:2530023, Exp.: 7/12/2025"}, {"status": "Ongoing", "city": "Basking Ridge", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA206937"], "brand_name": ["FLUOXETINE"], "generic_name": ["FLUOXETINE"], "manufacturer_name": ["Torrent Pharmaceuticals Limited"], "product_ndc": ["13668-443", "13668-473"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["FLUOXETINE HYDROCHLORIDE"], "rxcui": ["2532159", "2532163"], "spl_id": ["f8d8c930-c8f9-4186-92fa-6f7a5dabe083"], "spl_set_id": ["dcebc7cf-6f95-4f7a-a22b-c7d2e0f04d74"], "package_ndc": ["13668-443-74", "13668-443-10", "13668-443-01", "13668-443-30", "13668-443-91", "13668-473-10", "13668-473-74", "13668-473-30", "13668-473-01", "13668-473-91", "13668-473-70"], "is_original_packager": [true], "upc": ["0313668443301", "0313668473308"], "unii": ["I9W7N6B1KJ"]}, "product_type": "Drugs", "event_id": "96983", "recalling_firm": "Torrent Pharma Inc.", "address_1": "106 Allen Rd Ste 305", "address_2": "N/A", "postal_code": "07920-3851", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "U.S. Nationwide.", "recall_number": "D-0456-2025", "product_description": "Fluoxetine Tablets, USP, 20 mg, 28-count Carton (4x7 Unit-dose), Manufactured by: TORRENT PHARMACEUTIALS LTD., Indrad-382 721 INDIA; Manufactured for: TORRENT PHARMA INC., Basking Ridge, NJ 07920. NDC: 13668-473-91 (Carton); 13668-473-70 (Blister)", "product_quantity": "972 Cartons", "reason_for_recall": "CGMP Deviations: Presence of N-Nitroso Fluoxetine exceeding interim acceptable intake limit.", "recall_initiation_date": "20250527", "center_classification_date": "20250602", "report_date": "20250611", "code_info": "Lot# BDX6K001; Exp. Date: 06/30/2025"}, {"status": "Ongoing", "city": "Columbus", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA079175"], "brand_name": ["INDOMETHACIN"], "generic_name": ["INDOMETHACIN"], "manufacturer_name": ["American Health Packaging"], "product_ndc": ["68084-411"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["INDOMETHACIN"], "rxcui": ["310992"], "spl_id": ["2539d4a3-4162-ab7e-e063-6394a90aae5e"], "spl_set_id": ["5a65b650-ea9b-4d0d-b62f-5971df1e62b4"], "package_ndc": ["68084-411-11", "68084-411-21"], "original_packager_product_ndc": ["10702-016"], "nui": ["N0000000160", "M0001335", "N0000175722"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]"], "unii": ["XXE1CET956"]}, "product_type": "Drugs", "event_id": "96898", "recalling_firm": "Amerisource Health Services LLC", "address_1": "2550 John Glenn Ave Ste A", "address_2": "N/A", "postal_code": "43217-1188", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0454-2025", "product_description": "Indomethacin Extended-Release Capsules, USP, 75 mg, 30 capsules (3 x 10 blister cards) per carton, Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217, NDC 68084-411-21 (carton), NDC 68084-411-11 (blister card).", "product_quantity": "21 cartons", "reason_for_recall": "cGMP deviations", "recall_initiation_date": "20250515", "center_classification_date": "20250602", "report_date": "20250611", "code_info": "Lot #: 1021950, Exp. 11/30/2026"}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA078314"], "brand_name": ["NAPROXEN SODIUM"], "generic_name": ["NAPROXEN SODIUM"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "product_ndc": ["68462-178", "68462-188", "68462-189", "68462-190", "68462-179"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["NAPROXEN SODIUM"], "rxcui": ["198012", "198013", "198014", "849398", "849431"], "spl_id": ["b7cce793-fe49-4fe0-8848-fc89f7ea3832"], "spl_set_id": ["6c5bb008-e66f-4ef0-bf84-aca7eb5983e9"], "package_ndc": ["68462-188-01", "68462-188-05", "68462-189-01", "68462-189-05", "68462-190-30", "68462-190-50", "68462-190-01", "68462-190-05", "68462-178-01", "68462-178-05", "68462-179-01", "68462-179-05"], "is_original_packager": [true], "upc": ["0368462179017", "0368462178010", "0368462189016", "0368462188019", "0368462190012"], "nui": ["N0000000160", "M0001335", "N0000175722"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]"], "unii": ["57Y76R9ATQ", "9TN87S3A3C"]}, "product_type": "Drugs", "event_id": "96474", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0346-2025", "product_description": "Naproxen Sodium Tablets, USP, 550mg, 100-count bottles, Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh 454775, India, Manufactured for: Glenmark Pharmaceuticals Inc. USA, Mahwah, NJ 07430. NDC# 68462-179-01", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20250313", "center_classification_date": "20250408", "report_date": "20250416", "code_info": "Lot #  17231956, exp. date Aug-25"}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA077987"], "brand_name": ["PRAVASTATIN SODIUM"], "generic_name": ["PRAVASTATIN SODIUM"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "product_ndc": ["68462-195", "68462-196", "68462-197", "68462-198"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["PRAVASTATIN SODIUM"], "rxcui": ["904458", "904467", "904475", "904481"], "spl_id": ["a6e006b3-4256-4cbb-8ad1-b71f363430cd"], "spl_set_id": ["6ca01de3-a0f9-4cfb-b36a-723c7c42e2a4"], "package_ndc": ["68462-195-90", "68462-195-05", "68462-196-90", "68462-196-05", "68462-197-90", "68462-197-05", "68462-198-90", "68462-198-05"], "is_original_packager": [true], "upc": ["0368462195901", "0368462198902"], "unii": ["3M8608UQ61"]}, "product_type": "Drugs", "event_id": "96474", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0341-2025", "product_description": "Pravastatin Sodium Tablets, 20mg, a).500-count bottle (NDC# 68462-196-05), b). 90-count bottle (NDC# 68462-196-90), Rx only, Manufactured by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh 454775, India, Manufactured for: Glenmark Pharmaceuticals Inc. USA, Mahwah, NJ 07430.", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20250313", "center_classification_date": "20250408", "report_date": "20250416", "code_info": "Lot #  17230810, exp. date Mar-26 17230811, exp. date Mar-26 17230810, exp. date  Mar-26 17232501, exp. date Nov-26 17232502, exp. date Nov-26"}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA078251"], "brand_name": ["CARVEDILOL"], "generic_name": ["CARVEDILOL"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "product_ndc": ["68462-162", "68462-163", "68462-164", "68462-165"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CARVEDILOL"], "rxcui": ["200031", "200032", "200033", "686924"], "spl_id": ["5f5b2d20-cc2a-4e91-b2b9-260e7438ab2c"], "spl_set_id": ["c4a21f67-7812-4634-beba-f8e85c63c5f2"], "package_ndc": ["68462-162-60", "68462-162-01", "68462-162-18", "68462-162-05", "68462-162-10", "68462-163-60", "68462-163-01", "68462-163-18", "68462-163-05", "68462-163-10", "68462-164-60", "68462-164-01", "68462-164-18", "68462-164-05", "68462-164-10", "68462-165-60", "68462-165-01", "68462-165-18", "68462-165-05", "68462-165-10"], "is_original_packager": [true], "upc": ["0368462162019", "0368462163016", "0368462164013", "0368462165010"], "nui": ["N0000000099", "N0000009923", "N0000009924", "N0000175553", "N0000175556"], "pharm_class_moa": ["Adrenergic alpha-Antagonists [MoA]", "Adrenergic beta1-Antagonists [MoA]", "Adrenergic beta2-Antagonists [MoA]"], "pharm_class_epc": ["alpha-Adrenergic Blocker [EPC]", "beta-Adrenergic Blocker [EPC]"], "unii": ["0K47UL67F2"]}, "product_type": "Drugs", "event_id": "96861", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0450-2025", "product_description": "Carvedilol Tablets USP 12.5 mg, 500-Count bottle, Rx Only, Manufactured by: Glenmark Pharmaceuticals Ltd., Manufactured for Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ 07430.  NDC: 68462-164-05", "product_quantity": "84,048 bottles", "reason_for_recall": "CGMP Deviations; presence 'N-Nitroso Carvedilol I' Impurity above the recommended acceptable intake limit", "recall_initiation_date": "20250228", "center_classification_date": "20250528", "report_date": "20250604", "code_info": "Lot, Exp: Lots 19231899, 19231922, 19231927, 19231967, 19231979, Exp Apr-25; Lots 19232226, 19232234, 19232265, 1923227,1 Exp May-25; Lots 19232758, 19232759, 19232762, 19232788, Exp Jun-25"}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA212969"], "brand_name": ["METFORMIN HYDROCHLORIDE"], "generic_name": ["METFORMIN HYDROCHLORIDE"], "manufacturer_name": ["GLENMARK PHARMACEUTICALS INC., USA"], "product_ndc": ["68462-520", "68462-521"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["METFORMIN HYDROCHLORIDE"], "rxcui": ["1807888", "1807915"], "spl_id": ["ef160cca-85e2-440c-997f-0535914b4d3f"], "spl_set_id": ["0ef9de1a-b786-4b6c-a250-3f5ac532b16a"], "package_ndc": ["68462-520-01", "68462-520-05", "68462-520-10", "68462-521-90", "68462-521-01", "68462-521-05"], "is_original_packager": [true], "unii": ["786Z46389E"]}, "product_type": "Drugs", "event_id": "96474", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0328-2025", "product_description": "Metformin Hydrochloride Extended-Release Tablets 1000mg, 90-count bottle. Manufactured by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh 454775, India, Manufactured for: Glenmark Pharmaceuticals Inc. USA, Mahwah, NJ 07430. NDC 68462-521-90.", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20250313", "center_classification_date": "20250408", "report_date": "20250416", "code_info": "Lot #  17232088, exp. date Sep-25 17232093, exp. date Sep-25"}, {"status": "Ongoing", "city": "Pennington", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA213368"], "brand_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "generic_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "manufacturer_name": ["Zydus Pharmaceuticals (USA) Inc."], "product_ndc": ["70710-1129", "70710-1130", "70710-1131", "70710-1132", "70710-1133"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "rxcui": ["991039", "991044", "991188", "991194", "991336"], "spl_id": ["8a5df7d8-ad17-44d7-9c56-44fa2aaa0852"], "spl_set_id": ["fc2bd95d-a7bc-4ab5-bffa-f5059cb8eb63"], "package_ndc": ["70710-1129-1", "70710-1129-2", "70710-1129-4", "70710-1130-1", "70710-1130-2", "70710-1130-4", "70710-1131-1", "70710-1131-2", "70710-1131-4", "70710-1132-1", "70710-1132-2", "70710-1132-4", "70710-1133-1", "70710-1133-2", "70710-1133-4"], "is_original_packager": [true], "upc": ["0370710112912", "0370710113216", "0370710113018"], "unii": ["9WP59609J6"]}, "product_type": "Drugs", "event_id": "96626", "recalling_firm": "Zydus Pharmaceuticals (USA) Inc", "address_1": "73 Route 31 N", "address_2": "N/A", "postal_code": "08534-3601", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within U.S - MS, AL, TN, VT, OH, ND, MN, WI, SC, AR, FL, IN, LA, NJ, AZ, TX, KY and PA", "recall_number": "D-0361-2025", "product_description": "chlorproMAZINE Hydrochloride Tablets, USP 10 mg, Rx Only, 100 Tablets bottles, Manufactured by: Zydus Lifesciences Ltd., Baddi, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 70710-1129-1", "product_quantity": "3144 bottles, pack size: 100's Count", "reason_for_recall": "CGMP deviations: presence of N-Nitroso-Desmethyl Chlorpromazine impurity above the recommended interim limit", "recall_initiation_date": "20250403", "center_classification_date": "20250410", "report_date": "20250416", "code_info": "Lot #: Z400069, Exp.: 12/31/2025"}, {"status": "Ongoing", "city": "Historic New Castle", "state": "DE", "country": "United States", "classification": "Class II", "openfda": {"brand_name": ["URODEL"], "generic_name": ["CANTHARIS, CLEMATIS, CUBEBA, ECHINACEA, RANUNCULUS BULBOSUS, SABAL SERRULATA, STAPHYSAGRIA, UVA URSI"], "manufacturer_name": ["Pharmadel LLC"], "product_ndc": ["55758-406"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["ARCTOSTAPHYLOS UVA-URSI LEAF", "CLEMATIS RECTA FLOWERING TOP", "DELPHINIUM STAPHISAGRIA SEED", "ECHINACEA ANGUSTIFOLIA", "LYTTA VESICATORIA", "PIPER CUBEBA FRUIT", "RANUNCULUS BULBOSUS", "SAW PALMETTO"], "spl_id": ["3bdf040f-d0a4-e6db-e063-6394a90aaf3f"], "spl_set_id": ["0427bbc9-f4cc-0eb6-e063-6294a90a7199"], "package_ndc": ["55758-406-30"], "is_original_packager": [true], "unii": ["3M5V3D1X36", "396421SP9F", "00543AP1JV", "VB06AV5US8", "3Q034RO3BT", "Z99L7429MA", "AEQ8NXJ0MB", "J7WWH9M8QS"]}, "product_type": "Drugs", "event_id": "96639", "recalling_firm": "Pharmadel, LLC", "address_1": "650 Centerpoint Blvd", "address_2": "N/A", "postal_code": "19720-8108", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "DE", "recall_number": "D-0384-2025", "product_description": "Urodel, Urinary Tract Infection Symptoms Relief, Homeopathic, 30 chewable tablets per bottle, Distributed by: Pharmadel, New Castle, DE 19720, NDC 55758-406-30", "product_quantity": "10,752 bottles", "reason_for_recall": "cGMP deviations", "recall_initiation_date": "20250415", "center_classification_date": "20250421", "report_date": "20250430", "code_info": "Lot, expiry: UDE-01, EXP: OCT 26"}, {"status": "Ongoing", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA215256"], "brand_name": ["WEGOVY"], "generic_name": ["SEMAGLUTIDE"], "manufacturer_name": ["Novo Nordisk"], "product_ndc": ["0169-4501", "0169-4525", "0169-4505", "0169-4517", "0169-4524"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["SUBCUTANEOUS"], "substance_name": ["SEMAGLUTIDE"], "rxcui": ["2553501", "2553506", "2553601", "2553603", "2553802", "2553803", "2553901", "2553903", "2554102", "2554104"], "spl_id": ["4b92e0b3-da0b-4c1a-a926-295b389a1a57"], "spl_set_id": ["ee06186f-2aa3-4990-a760-757579d8f77b"], "package_ndc": ["0169-4525-01", "0169-4525-14", "0169-4525-90", "0169-4525-94", "0169-4505-01", "0169-4505-14", "0169-4501-01", "0169-4501-14", "0169-4517-01", "0169-4517-14", "0169-4524-01", "0169-4524-14"], "is_original_packager": [true], "nui": ["N0000178480", "M0160181", "N0000020058"], "pharm_class_epc": ["GLP-1 Receptor Agonist [EPC]"], "pharm_class_cs": ["Glucagon-Like Peptide 1 [CS]"], "pharm_class_moa": ["Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]"], "unii": ["53AXN4NNHX"]}, "product_type": "Drugs", "event_id": "96637", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "NC, SC, VA", "recall_number": "D-0393-2025", "product_description": "Wegovy (semaglutide) injection, 2.4 mg/0.75 mL, 4 Single-Dose Prefilled Pens per Carton, For Subcutaneous Use Only, Rx Only, Single-Dose Only, Novo Nordisk Inc., Plainsboro, NJ 08536, Manufactured by: Novo Nordisk A/S, DK-2880, Bagsvaerd, Denmark, NDC 0169-4524-14.", "product_quantity": "48 Cartons", "reason_for_recall": "Temperature abuse: Wegovy product was potentially exposed to temperatures outside of the products labeled storage conditions due to a shipping error involving a Cardinal Health distribution center. More specifically, product was removed from refrigerated storage for an extended period of time and inappropriately released.", "recall_initiation_date": "20250409", "center_classification_date": "20250428", "report_date": "20250507", "code_info": "Lot PZFDE06, Exp 08/31/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA209239"], "brand_name": ["SOLIFENACIN SUCCINATE"], "generic_name": ["SOLIFENACIN SUCCINATE"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "product_ndc": ["68462-386", "68462-387"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["SOLIFENACIN SUCCINATE"], "rxcui": ["477367", "477372"], "spl_id": ["9cfcab1d-64ac-457b-979f-41cf6547a63a"], "spl_set_id": ["010c0657-c907-477f-8bd7-5d455a5f50eb"], "package_ndc": ["68462-386-30", "68462-386-90", "68462-386-14", "68462-387-30", "68462-387-90", "68462-387-14"], "is_original_packager": [true], "upc": ["0368462386309", "0368462387306"], "unii": ["KKA5DLD701"]}, "product_type": "Drugs", "event_id": "96474", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0333-2025", "product_description": "Solifenacin Succinate Tablets 5mg, a.) 30-count bottle (NDC# 68462-386-30) b.) 90-count bottle (NDC# 68462-386-90), Rx Only. Manufactured by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh 454775, India, Manufactured for: Glenmark Pharmaceuticals Inc. USA, Mahwah, NJ 07430.", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20250313", "center_classification_date": "20250408", "report_date": "20250416", "code_info": "30 count bottle:  17232395, exp. date Nov-25 17232400, exp. date Nov-25  90-count bottle:  17232395, exp. date Nov-25"}, {"status": "Ongoing", "city": "Wilmington", "state": "DE", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA214070"], "brand_name": ["AIRSUPRA"], "generic_name": ["ALBUTEROL SULFATE AND BUDESONIDE"], "manufacturer_name": ["AstraZeneca Pharmaceuticals LP"], "product_ndc": ["0310-9080"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["RESPIRATORY (INHALATION)"], "substance_name": ["ALBUTEROL SULFATE", "BUDESONIDE"], "rxcui": ["2665906", "2665912", "2678391", "2678392"], "spl_id": ["8738de51-e5d3-4ac5-910d-a155169ab78e"], "spl_set_id": ["e60aa9f9-5139-44df-b886-ebddc3c7eb13"], "package_ndc": ["0310-9080-12", "0310-9080-28"], "is_original_packager": [true], "nui": ["N0000175576", "N0000175450"], "pharm_class_epc": ["Corticosteroid [EPC]"], "pharm_class_moa": ["Corticosteroid Hormone Receptor Agonists [MoA]"], "unii": ["021SEF3731", "Q3OKS62Q6X"]}, "product_type": "Drugs", "event_id": "96857", "recalling_firm": "AsttraZeneca Pharmaceuticals LP", "address_1": "1800 Concord Pike", "address_2": "N/A", "postal_code": "19897-0001", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide", "recall_number": "D-0444-2025", "product_description": "Airsupra (albuterol and budesonide) inhalation aerosol, 90 mcg/80 mcg per inhalation, packaged in a) 120-inhalation canister (NDC 0310-9080-12) b) 28-inhalation canister (NDC 0310-9080-28), Rx only, Manufactured for: AstraZeneca Pharmaceuticals LP, Wilmington, DE 19850, By: AstraZeneca Dunkerque Production (AZDP), Dunkerque, France, Product of France, .", "product_quantity": "a) 807,837 canisters; b)  235,698 canisters", "reason_for_recall": "Defective delivery system", "recall_initiation_date": "20250514", "center_classification_date": "20250521", "report_date": "20250528", "code_info": "Lot#:  a) 6270044C00, 6270040D00, 6270034E00, Exp Date 10/2026; 6270053C00, 6270045C00, 6270047C00, 6270056C00, 6270052C00, 6270063E00 Exp 11/30/2026; 6270064C00, 6270071D00, 6270075D00, 6270075F00 Exp Date 12/31/2026; 6270107C00, Exp Date 9/30/2027; b) Lot 6270019E00, Exp Date 7/31/2025; 6270021D00, Exp 8/31/2025; 6270095C00, Exp 2/28/2026"}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA077662"], "brand_name": ["GABAPENTIN"], "generic_name": ["GABAPENTIN"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "product_ndc": ["68462-126", "68462-127"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["GABAPENTIN"], "rxcui": ["310433", "310434"], "spl_id": ["5c6de7e2-6f75-426a-a832-5cea5c70b43e"], "spl_set_id": ["3865a6e3-112c-490c-82ac-35401336b16e"], "package_ndc": ["68462-126-01", "68462-126-05", "68462-127-01", "68462-127-05"], "is_original_packager": [true], "upc": ["0368462127018", "0368462126011"], "nui": ["N0000008486"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "unii": ["6CW7F3G59X"]}, "product_type": "Drugs", "event_id": "96474", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0320-2025", "product_description": "Gabapentin Tablets 600mg, 500-count bottles, Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh 454775, India, Manufactured for: Glenmark Pharmaceuticals Inc. USA, Mahwah, NJ 07430. NDC# 68462-126-05.", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20250313", "center_classification_date": "20250408", "report_date": "20250416", "code_info": "Lot # 17231015, exp. date Apr-25 17231128, exp. date Apr-25 17231138, exp. date Apr-25 17231139, exp. date Apr-25 17231143, exp. date Apr-25 17231144, exp. date Apr-25 17231848, exp. date Aug-25 17231898, exp. date Aug-25 17231977, exp. date Aug-25 17231978, exp. date Aug-25 17232015, exp. date Aug-25 17232016, exp. date Aug-25 17232017, exp. date Aug-25 17232034, exp. date Aug-25 17232041, exp. date Aug-25 17232396, exp. date Nov-25 17232406, exp. date Nov-25 17232410, exp. date Nov-25 17232490, exp. date Nov-25 17240326, exp. date Jan-26 17240327, exp. date Jan-26 17240383, exp. date Feb-26 17240395, exp. date Feb-26 17241863, exp. date Oct-26 17241869, exp. date Oct-26 17241870, exp. date Oct-26 17231256, exp. date May-25 17231386, exp. date May-25 17231387, exp. date May-25 17231407, exp. date May-25 17231417, exp. date May-25 17231418, exp. date May-25 17231754, exp. date Jul-25 17240085, exp. date Dec-25 17240117, exp. date Dec-25 17240131, exp. date Dec-25"}, {"status": "Ongoing", "city": "Smyrna", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M003"], "brand_name": ["HYDROGEN PEROXIDE"], "generic_name": ["HYDROGEN PEROXIDE"], "manufacturer_name": ["Vi-Jon, LLC"], "product_ndc": ["0869-0871"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["HYDROGEN PEROXIDE"], "rxcui": ["91349"], "spl_id": ["3deb136a-9aee-4364-e063-6294a90a626f"], "spl_set_id": ["e0a07631-6770-48b3-bf7b-19f3f3965cd9"], "package_ndc": ["0869-0871-72", "0869-0871-43", "0869-0871-45", "0869-0871-18", "0869-0871-99", "0869-0871-82"], "is_original_packager": [true], "unii": ["BBX060AN9V"]}, "product_type": "Drugs", "event_id": "96475", "recalling_firm": "Consumer Product Partners, LLC", "address_1": "1 Swan Dr", "address_2": "N/A", "postal_code": "37167-2099", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "VA", "recall_number": "D-0302-2025", "product_description": "[CORRECT FRONT PANEL] Hydrogen Peroxide Topical Solution, USP, 32 FL OZ (1 QT) 946 mL per bottle, NDC 0869-0871-45; [INCORRECT BACK LABEL] Isopropyl alcohol 91%, Dist. by: Amazon.com Services, LLC, Seattle, WA 98109.", "product_quantity": "25,932 bottles", "reason_for_recall": "Labeling; Label Mixup; some bottles have an incorrect back label indicating 91% Isopropyl Alcohol", "recall_initiation_date": "20250307", "center_classification_date": "20250327", "report_date": "20250402", "code_info": "Lot 0643188, exp. date 10/22/2026"}, {"status": "Ongoing", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA077242"], "brand_name": ["GABAPENTIN"], "generic_name": ["GABAPENTIN"], "manufacturer_name": ["Sun Pharmaceutical Industries, Inc."], "product_ndc": ["62756-137", "62756-138", "62756-139", "62756-202", "62756-204"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["GABAPENTIN"], "spl_id": ["aff50a15-df39-495f-a145-0ba59660eed8"], "spl_set_id": ["c9a05f0c-b5f0-422c-9d67-6d0efc921a74"], "package_ndc": ["62756-137-02", "62756-137-03", "62756-137-05", "62756-137-04", "62756-137-01", "62756-138-02", "62756-138-03", "62756-138-05", "62756-138-04", "62756-138-01", "62756-139-02", "62756-139-03", "62756-139-05", "62756-139-04", "62756-139-01", "62756-202-01", "62756-202-03", "62756-204-01", "62756-204-03"], "is_original_packager": [true], "upc": ["0362756204010", "0362756202016", "0362756138025", "0362756137028", "0362756139022"], "nui": ["N0000008486"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "unii": ["6CW7F3G59X"]}, "product_type": "Drugs", "event_id": "96415", "recalling_firm": "SUN PHARMACEUTICAL INDUSTRIES INC", "address_1": "2 Independence Way", "address_2": "N/A", "postal_code": "08540-6620", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0312-2025", "product_description": "Gabapentin Capsules, USP 400 mg, Rx Only, Packaged in a) 500-count bottles, NDC 62756-139-05; b) 1000-count bottles, NDC 62756-139-04; Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Ltd. Halol-Baroda Highway, Halol-389 350, Gujarat, India.", "product_quantity": "852 bottles", "reason_for_recall": "Cross Contamination", "recall_initiation_date": "20250304", "center_classification_date": "20250404", "report_date": "20250416", "code_info": "Lot # a) HAD1712B, Exp. date 03/2025 b) HAD1712C, exp. date 03/2025"}, {"status": "Ongoing", "city": "Pennington", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA077653"], "brand_name": ["VENLAFAXINE"], "generic_name": ["VENLAFAXINE"], "manufacturer_name": ["Zydus Pharmaceuticals USA Inc."], "product_ndc": ["68382-018", "68382-019", "68382-020", "68382-021", "68382-101"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["VENLAFAXINE HYDROCHLORIDE"], "rxcui": ["313580", "313582", "313584", "313586", "314277"], "spl_id": ["ea404f6c-7e07-4779-a52c-8cffb92718ef"], "spl_set_id": ["72efad5f-0909-46a5-aa13-ac24fe015fe6"], "package_ndc": ["68382-018-06", "68382-018-14", "68382-018-16", "68382-018-01", "68382-018-05", "68382-018-10", "68382-019-06", "68382-019-14", "68382-019-16", "68382-019-01", "68382-019-05", "68382-019-10", "68382-020-06", "68382-020-14", "68382-020-16", "68382-020-01", "68382-020-05", "68382-020-10", "68382-021-06", "68382-021-14", "68382-021-16", "68382-021-01", "68382-021-05", "68382-021-10", "68382-101-06", "68382-101-14", "68382-101-16", "68382-101-01", "68382-101-05", "68382-101-10"], "is_original_packager": [true], "upc": ["0368382019011", "0368382018014", "0368382021014", "0368382101013"], "unii": ["7D7RX5A8MO"]}, "product_type": "Drugs", "event_id": "96553", "recalling_firm": "Zydus Pharmaceuticals (USA) Inc", "address_1": "73 Route 31 N", "address_2": "N/A", "postal_code": "08534-3601", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "US Nationwide.", "recall_number": "D-0310-2025", "product_description": "Venlafaxine Tablets, USP, 75 mg, 100 Tablets, Rx only, Mfg. by: Zydus Lifesciences Ltd, Ahmedabad, India, Dist. by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 68382-021-01.", "product_quantity": "13,128 100-Count Bottles", "reason_for_recall": "Presence of Foreign Substance: Product complaint received for the presence of foreign material embedded resembling a metal shaving in one tablet.", "recall_initiation_date": "20250321", "center_classification_date": "20250404", "report_date": "20250416", "code_info": "Lot #: M314265, Exp.: 31 October 2025."}, {"status": "Ongoing", "city": "Historic New Castle", "state": "DE", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96639", "recalling_firm": "Pharmadel, LLC", "address_1": "650 Centerpoint Blvd", "address_2": "N/A", "postal_code": "19720-8108", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "DE", "recall_number": "D-0379-2025", "product_description": "DoloDent Maximum Strength Toothache Drops, Homeopathic Oral Drops, 0.50 oz fl (15 mL), Distributed by: Pharmadel, New Castle, DE 19720, NDC 55758-400-15", "product_quantity": "9504 bottles", "reason_for_recall": "cGMP deviations", "recall_initiation_date": "20250415", "center_classification_date": "20250421", "report_date": "20250430", "code_info": "Lot EDD-01"}, {"status": "Ongoing", "city": "Indiana", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96764", "recalling_firm": "RemedyRePack Inc.", "address_1": "625 Kolter Dr Ste 4", "address_2": "N/A", "postal_code": "15701-3571", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Within U.S - PA, VA, FL.", "recall_number": "D-0411-2025", "product_description": "Clindamycin HCl Capsule, 300 mg, QTY: 30 Capsules per bottle, Rx Only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701. NDC#: 70518-3772-02", "product_quantity": "23 bottles/30 count- 690 capsules", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20250422", "center_classification_date": "20250506", "report_date": "20250514", "code_info": "Lot#: B3698036-033125, B3688703-032625, Exp.: 07/31/2026.", "more_code_info": ""}, {"status": "Ongoing", "city": "East Windsor", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA216379"], "brand_name": ["TIROFIBAN"], "generic_name": ["TIROFIBAN"], "manufacturer_name": ["Eugia US LLC"], "product_ndc": ["55150-429", "55150-430"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["TIROFIBAN HYDROCHLORIDE"], "rxcui": ["1737466", "1737471"], "spl_id": ["1751523a-e22e-4faf-bdb1-c850afe2fd36"], "spl_set_id": ["d554acff-22e9-4f28-b826-ee1b91daa2df"], "package_ndc": ["55150-429-01", "55150-430-01"], "is_original_packager": [true], "upc": ["0355150430017", "0355150429011"], "unii": ["6H925F8O5J"]}, "product_type": "Drugs", "event_id": "96718", "recalling_firm": "Eugia US LLC", "address_1": "279 Princeton Hightstown Rd", "address_2": "N/A", "postal_code": "08520-1401", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide.", "recall_number": "D-0390-2025", "product_description": "Tirofiban Hydrochloride Injection 12.5 mg/250 mL (50 mcg/mL), 250 mL single-dose container (bag), Rx only, Manufactured in India for: Eugia U.S. LLC, 279 Princeton-Hightstown Rd., E. Windsor, NJ 08520, NDC 55150-430-01", "product_quantity": "N/A", "reason_for_recall": "Out-of-Specification test results were obtained in at long term conditions during 3 month's stability study for related substances.", "recall_initiation_date": "20250421", "center_classification_date": "20250425", "report_date": "20250507", "code_info": "Lot# : 3TF24001, Exp 3/31/2026", "more_code_info": ""}, {"status": "Ongoing", "city": "Pennington", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA217656"], "brand_name": ["ICOSAPENT ETHYL"], "generic_name": ["ICOSAPENT ETHYL"], "manufacturer_name": ["Zydus Pharmaceuticals USA Inc."], "product_ndc": ["70710-1592", "70710-1738"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ICOSAPENT ETHYL"], "rxcui": ["1304979", "1811180"], "spl_id": ["b292c3ea-8ce0-471f-8c44-57d1c4df9bf5"], "spl_set_id": ["5910742b-c5e6-4029-9a19-97669e3808bc"], "package_ndc": ["70710-1738-4", "70710-1592-7"], "is_original_packager": [true], "upc": ["0370710159276"], "unii": ["6GC8A4PAYH"]}, "product_type": "Drugs", "event_id": "96964", "recalling_firm": "Zydus Pharmaceuticals (USA) Inc", "address_1": "73 Route 31 N", "address_2": "", "postal_code": "08534-3601", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "IL, PA, & MS", "recall_number": "D-0497-2025", "product_description": "Icosapent Ethyl Capsules 1 gram, 120 Capsules per Bottle, Rx Only, Manufactured by Doppel Farmaceutici s.r.l., Piacenza, Italy, Distributed by Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 70710-1592-7.", "product_quantity": "11,616 bottles", "reason_for_recall": "Failed Tablet/Capsule specifications; a product complaint was reported for burnt or melted capsules. This was determined to be a result of oxidation by leakage of capsule contents.", "recall_initiation_date": "20250530", "center_classification_date": "20250630", "report_date": "20250618", "code_info": "Lot #s: B237040, B237041, Exp 10/31/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Ta. Kadi, District Mehsana", "state": "N/A", "country": "India", "classification": "Class II", "openfda": {"application_number": ["M021"], "brand_name": ["NATURE MINT ANTICAVITY"], "generic_name": ["SODIUM MONOFLUOROPHOSPHATE"], "manufacturer_name": ["Bob Barker Company Inc."], "product_ndc": ["53247-131"], "product_type": ["HUMAN OTC DRUG"], "route": ["DENTAL"], "substance_name": ["SODIUM MONOFLUOROPHOSPHATE"], "rxcui": ["545626"], "spl_id": ["25cae217-37ed-403c-8a97-acfae13ef681"], "spl_set_id": ["39e9c844-d2c2-4e3c-84c0-bdb767a03f7b"], "package_ndc": ["53247-131-01", "53247-131-02", "53247-131-03", "53247-131-04", "53247-131-05", "53247-131-06", "53247-131-07"], "is_original_packager": [true], "unii": ["C810JCZ56Q"]}, "product_type": "Drugs", "event_id": "96797", "recalling_firm": "KENIL HEALTHCARE PRIVATE LIMITED", "address_1": "Plot 319", "address_2": "Village Acharasan, Ankhol-Vamaj Road", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "DE and NC", "recall_number": "D-0439-2025", "product_description": "Nature Mint Anticavity Fluoride Toothpaste, Sodium monofluorophosphate 0.76%, NET WT 1.5 OZ (43 grams) Tube, Made in India, Dist. by Bob Barker Co. Inc., Fuquay-Varina, NC 27526, NDC 53247-131-04", "product_quantity": "150,768 Tubes", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20250424", "center_classification_date": "20250519", "report_date": "20250528", "code_info": "Lot B0004, Exp Date: 05/31/2026; B0060, Exp Date: 07/31/2026; Lot B0067, B0071, B0072, Exp Date: 08/31/2026; Lot B0107, B0108, Exp Date: 09/30/2026"}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA216595"], "brand_name": ["PROCHLORPERAZINE MALEATE"], "generic_name": ["PROCHLORPERAZINE MALEATE"], "manufacturer_name": ["GLENMARK PHARMACEUTICALS INC., USA"], "product_ndc": ["68462-889", "68462-890", "68462-947"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["PROCHLORPERAZINE MALEATE"], "rxcui": ["198365", "312635"], "spl_id": ["c56758e4-6b1c-4ad1-a342-452dfd4d5679"], "spl_set_id": ["9c806152-70d0-43eb-b183-b51b12b82b31"], "package_ndc": ["68462-889-01", "68462-889-10", "68462-890-01", "68462-890-10", "68462-947-01", "68462-947-10"], "is_original_packager": [true], "upc": ["0368462889015", "0368462947012"], "unii": ["I1T8O1JTL6"]}, "product_type": "Drugs", "event_id": "96474", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0338-2025", "product_description": "Prochlorperazine Maleate Tablets, 10mg, 100-count bottles, Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh 454775, India, Manufactured for: Glenmark Pharmaceuticals Inc. USA, Mahwah, NJ 07430. NDC# 68462-890-01", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20250313", "center_classification_date": "20250408", "report_date": "20250416", "code_info": "Lot #  17240254, exp. date Jan-26 17240257, exp. date Jan-26"}, {"status": "Ongoing", "city": "Lenoir", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA211091"], "brand_name": ["SODIUM BICARBONATE"], "generic_name": ["SODIUM BICARBONATE"], "manufacturer_name": ["Exela Pharma Sciences, LLC"], "product_ndc": ["51754-5001", "51754-5011", "51754-5002", "51754-5012"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["SODIUM BICARBONATE"], "rxcui": ["807284", "1868486", "1923484", "2198792"], "spl_id": ["4da0ba66-756d-4b4d-8018-81ca16578ef1"], "spl_set_id": ["e9698a4f-1a95-4f28-a945-e8009d1d6dd4"], "package_ndc": ["51754-5001-5", "51754-5001-4", "51754-5011-4", "51754-5002-5", "51754-5012-4", "51754-5001-1"], "is_original_packager": [true], "unii": ["8MDF5V39QO"]}, "product_type": "Drugs", "event_id": "96481", "recalling_firm": "Exela Pharma Sciences LLC", "address_1": "1245 Blowing Rock Blvd", "address_2": "N/A", "postal_code": "28645-3618", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0303-2025", "product_description": "8.4% Sodium Bicarbonate Injection, USP, 50 mEq/50 mL (1 mEq/mL), 25 x 50 mL Single Dose Vials per carton, For Intravenous Use Only, Rx Only, Manufactured by: Exela Pharma Sciences, LLC, Lenoir, NC 28645. NDC Inner Vial: 51754-5001-1; NDC Carton: 51754-5001-4", "product_quantity": "103,950 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20250307", "center_classification_date": "20250327", "report_date": "20250402", "code_info": "Lots: 10006417 and 10006418, Exp. 11/30/2026"}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA205994"], "brand_name": ["SAXAGLIPTIN"], "generic_name": ["SAXAGLIPTIN"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "product_ndc": ["68462-726", "68462-727"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["SAXAGLIPTIN HYDROCHLORIDE"], "rxcui": ["858036", "858042"], "spl_id": ["e286ffd4-c598-47fb-af06-2e15f7e6f99f"], "spl_set_id": ["e286ffd4-c598-47fb-af06-2e15f7e6f99f"], "package_ndc": ["68462-726-30", "68462-726-90", "68462-726-05", "68462-727-30", "68462-727-90", "68462-727-05", "68462-727-14"], "is_original_packager": [true], "upc": ["0368462726907"], "unii": ["Z8J84YIX6L"]}, "product_type": "Drugs", "event_id": "96474", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0345-2025", "product_description": "Saxagliptin Tablets, USP, 2.5mg, a). 30-count bottle (NDC# 68462-726-30), b).90-count bottle(NDC# 68462-726-90), Manufactured by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh 454775, India, Manufactured for: Glenmark Pharmaceuticals Inc. USA, Mahwah, NJ 07430.", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20250313", "center_classification_date": "20250408", "report_date": "20250416", "code_info": "30-Count Bottle Lots:   17241788, exp. date Sep-26 17241821, exp. date Sep-26 17241822, exp. date Sep-26   90-Count Bottle Lot:  17241822, exp. date Sept 26"}, {"status": "Ongoing", "city": "Ta. Kadi, District Mehsana", "state": "N/A", "country": "India", "classification": "Class II", "openfda": {"application_number": ["M021"], "brand_name": ["NATURE MINT ANTICAVITY"], "generic_name": ["SODIUM MONOFLUOROPHOSPHATE"], "manufacturer_name": ["Bob Barker Company Inc."], "product_ndc": ["53247-131"], "product_type": ["HUMAN OTC DRUG"], "route": ["DENTAL"], "substance_name": ["SODIUM MONOFLUOROPHOSPHATE"], "rxcui": ["545626"], "spl_id": ["25cae217-37ed-403c-8a97-acfae13ef681"], "spl_set_id": ["39e9c844-d2c2-4e3c-84c0-bdb767a03f7b"], "package_ndc": ["53247-131-01", "53247-131-02", "53247-131-03", "53247-131-04", "53247-131-05", "53247-131-06", "53247-131-07"], "is_original_packager": [true], "unii": ["C810JCZ56Q"]}, "product_type": "Drugs", "event_id": "96797", "recalling_firm": "KENIL HEALTHCARE PRIVATE LIMITED", "address_1": "Plot 319", "address_2": "Village Acharasan, Ankhol-Vamaj Road", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "DE and NC", "recall_number": "D-0440-2025", "product_description": "Nature Mint, Anticavity Fluoride Toothpaste, Sodium monofluorophosphate 0.76%, NET WT 2.75 OZ (78g) Tube, Made in India, Dist. by Bob Barker Co. Inc., Fuquay-Varina, NC 27526, NDC 53247-131-05", "product_quantity": "160,848 Tubes", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20250424", "center_classification_date": "20250519", "report_date": "20250528", "code_info": "Lot B0032, B0047, B0048, B0055, B0056, Exp Date: 07/31/2026; B0102, B0103, B0104, B0105, B0106, B0107, Exp Date: 09/30/2026"}, {"status": "Ongoing", "city": "Ta. Kadi, District Mehsana", "state": "N/A", "country": "India", "classification": "Class II", "openfda": {"application_number": ["M021"], "brand_name": ["MAXIMUM SECURITY"], "generic_name": ["SODIUM FLUORIDE"], "manufacturer_name": ["Bob Barker Company Inc."], "product_ndc": ["53247-132"], "product_type": ["HUMAN OTC DRUG"], "route": ["DENTAL"], "substance_name": ["SODIUM FLUORIDE"], "rxcui": ["245598"], "spl_id": ["067a1e13-c34a-42b0-a16e-a343ff84bf91"], "spl_set_id": ["a89160b6-a204-46c7-8719-bb9c9ed6fe8a"], "package_ndc": ["53247-132-01", "53247-132-02", "53247-132-03", "53247-132-04", "53247-132-05"], "is_original_packager": [true], "unii": ["8ZYQ1474W7"]}, "product_type": "Drugs", "event_id": "96797", "recalling_firm": "KENIL HEALTHCARE PRIVATE LIMITED", "address_1": "Plot 319", "address_2": "Village Acharasan, Ankhol-Vamaj Road", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "DE and NC", "recall_number": "D-0434-2025", "product_description": "Maximum Security, Anticavity Gel Toothpaste, Sodium Fluoride 0.22%, Fresh Mint Flavor, NET WT 1.5 OZ (43 g) Tube, Made in India, Dist. by Bob Barker Co. Inc., Fuquay-Varina, NC 27526, NDC 53247-132-04", "product_quantity": "216,720 Tubes", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20250424", "center_classification_date": "20250519", "report_date": "20250528", "code_info": "Lot B0013, Exp Date: 05/31/2026; Lot B0018, Exp Date: 06/30/2026; Lot B0053, B0054, Exp Date: 07/31/2026; Lot B0090, B0091, B0092, B0093, B0094, B0095, B0096, B0097, B0098, B0099, B0100, B0101, Exp Date: 09/30/2026"}, {"status": "Ongoing", "city": "Pennington", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA206055"], "brand_name": ["ESOMEPRAZOLE MAGNESIUM"], "generic_name": ["ESOMEPRAZOLE MAGNESIUM"], "manufacturer_name": ["Zydus Pharmaceuticals USA Inc."], "product_ndc": ["68382-848", "68382-849"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ESOMEPRAZOLE MAGNESIUM DIHYDRATE"], "rxcui": ["692576", "692578"], "spl_id": ["bc31956a-671b-4ca3-b9dd-1fdb03003cae"], "spl_set_id": ["190a4c5b-1547-45d7-b00b-10da4131e2e2"], "package_ndc": ["68382-848-94", "68382-849-94"], "is_original_packager": [true], "unii": ["36H71644EQ"]}, "product_type": "Drugs", "event_id": "96860", "recalling_firm": "Zydus Pharmaceuticals (USA) Inc", "address_1": "73 Route 31 N", "address_2": "N/A", "postal_code": "08534-3601", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide -in the USA", "recall_number": "D-0443-2025", "product_description": "Esomeprazole Magnesium for Delayed-Release Oral Suspension, 20 mg, 30-count single dose packets per carton, Rx Only, Manufactured by: Zydus Lifesciences Ltd. Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534,  NDC 68382-848-94", "product_quantity": "22,152 30 sachets/carton", "reason_for_recall": "Failed Impurities/Degradation Specifications: Out-of-Specification test results obtained for any individual unknown degradation product during Related Compounds testing during long term stability.", "recall_initiation_date": "20250513", "center_classification_date": "20250520", "report_date": "20250528", "code_info": "Lot #:M402147, Exp 10/2025; M311637, Exp 07/2025; M402495, Exp 02/2026; M407997, Exp 05/2026; M502246, Exp11/2026."}, {"status": "Ongoing", "city": "Berlin", "state": "CT", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA203088"], "brand_name": ["DULOXETINE"], "generic_name": ["DULOXETINE HYDROCHLORIDE"], "manufacturer_name": ["Breckenridge Pharmaceutical, Inc."], "product_ndc": ["51991-746", "51991-747", "51991-748", "51991-750"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DULOXETINE HYDROCHLORIDE"], "rxcui": ["596926", "596930", "596934", "616402"], "spl_id": ["32327581-bdab-41ac-9adc-bf208e1c4e42"], "spl_set_id": ["caef6f50-1571-4ec7-8f8c-42b924d323ee"], "package_ndc": ["51991-746-06", "51991-746-90", "51991-746-05", "51991-747-33", "51991-747-90", "51991-747-10", "51991-748-33", "51991-748-90", "51991-748-10", "51991-750-33", "51991-750-90", "51991-750-05", "51991-750-10"], "is_original_packager": [true], "unii": ["9044SC542W"]}, "product_type": "Drugs", "event_id": "96707", "recalling_firm": "Breckenridge Pharmaceutical, Inc", "address_1": "15 Massirio Dr Ste 201", "address_2": "N/A", "postal_code": "06037-2352", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "US Nationwide.", "recall_number": "D-0387-2025", "product_description": "Duloxetine Delayed-Release Capsules USP, 60 mg, 1000-count bottles, Rx Only, Manufactured by Towa Pharmaceutical Europe, S.L., Distributed by Breckenridge Pharmaceutical, Inc. Berkeley Heights, NJ 07922, NDC# 51991-748-10", "product_quantity": "16,473 bottles", "reason_for_recall": "CGMP Deviations: Presence of Nitrosamine Drug Substance Related Impurity above the proposed interim limit.", "recall_initiation_date": "20250414", "center_classification_date": "20250422", "report_date": "20250430", "code_info": "Lot #  240987C, exp. date 04/2027 241014C, exp. date 04/2027"}, {"status": "Ongoing", "city": "Pulaski", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA210742"], "brand_name": ["CHLORTHALIDONE"], "generic_name": ["CHLORTHALIDONE"], "manufacturer_name": ["AvPAK"], "product_ndc": ["50268-167"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CHLORTHALIDONE"], "rxcui": ["197499"], "spl_id": ["df21e622-654c-2eab-e053-2995a90a5f1c"], "spl_set_id": ["972b801e-c4f2-4bd6-e053-2a95a90a53bb"], "package_ndc": ["50268-167-11", "50268-167-15"], "original_packager_product_ndc": ["43598-719"], "nui": ["N0000175359", "N0000175420"], "pharm_class_pe": ["Increased Diuresis [PE]"], "pharm_class_epc": ["Thiazide-like Diuretic [EPC]"], "unii": ["Q0MQD1073Q"]}, "product_type": "Drugs", "event_id": "96866", "recalling_firm": "AvKARE", "address_1": "615 N 1st St", "address_2": "", "postal_code": "38478-2403", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA", "recall_number": "D-0461-2025", "product_description": "Chlorthalidone Tablets, USP, 25 mg, 50 Tablets (5x10) Unit Dose cards per carton, Rx only, Manufactured for: AvKARE, Pulaski, TN 38478, NDC 50268-167-15", "product_quantity": "962 cartons", "reason_for_recall": "Failed Dissolution Specifications", "recall_initiation_date": "20250509", "center_classification_date": "20250609", "report_date": "20250618", "code_info": "Lot # 47947, Exp 05/31/2026", "more_code_info": ""}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA205006"], "brand_name": ["LACOSAMIDE"], "generic_name": ["LACOSAMIDE"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc. USA"], "product_ndc": ["68462-678", "68462-679", "68462-680", "68462-681"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LACOSAMIDE"], "rxcui": ["809987", "809992", "809996", "810000"], "spl_id": ["a65056ce-b6e9-4bed-adbd-98052a2e705e"], "spl_set_id": ["df1d2e6a-6129-49c9-b2c1-0fdf73f38b9c"], "package_ndc": ["68462-678-30", "68462-678-60", "68462-678-10", "68462-679-30", "68462-679-60", "68462-679-10", "68462-680-30", "68462-680-60", "68462-680-10", "68462-681-30", "68462-681-60", "68462-681-10"], "is_original_packager": [true], "upc": ["0368462680605", "0368462681602"], "nui": ["N0000008486"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "unii": ["563KS2PQY5"]}, "product_type": "Drugs", "event_id": "96474", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0343-2025", "product_description": "Lacosamide Tablets 150mg, 60-count bottle, Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh 454775, India, Manufactured for: Glenmark Pharmaceuticals Inc. USA, Mahwah, NJ 07430.NDC# 68462-680-60.", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20250313", "center_classification_date": "20250408", "report_date": "20250416", "code_info": "Lot #  17241125, exp. date Jun-26 17242202, exp. date  Nov-26 17242204, exp. date Dec-26"}, {"status": "Ongoing", "city": "Ta. Kadi, District Mehsana", "state": "N/A", "country": "India", "classification": "Class II", "openfda": {"application_number": ["M021"], "brand_name": ["MAXIMUM SECURITY"], "generic_name": ["SODIUM FLUORIDE"], "manufacturer_name": ["Bob Barker Company Inc."], "product_ndc": ["53247-132"], "product_type": ["HUMAN OTC DRUG"], "route": ["DENTAL"], "substance_name": ["SODIUM FLUORIDE"], "rxcui": ["245598"], "spl_id": ["067a1e13-c34a-42b0-a16e-a343ff84bf91"], "spl_set_id": ["a89160b6-a204-46c7-8719-bb9c9ed6fe8a"], "package_ndc": ["53247-132-01", "53247-132-02", "53247-132-03", "53247-132-04", "53247-132-05"], "is_original_packager": [true], "unii": ["8ZYQ1474W7"]}, "product_type": "Drugs", "event_id": "96797", "recalling_firm": "KENIL HEALTHCARE PRIVATE LIMITED", "address_1": "Plot 319", "address_2": "Village Acharasan, Ankhol-Vamaj Road", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "DE and NC", "recall_number": "D-0431-2025", "product_description": "Maximum Security Anticavity Gel Toothpaste, Sodium Fluoride 0.22%, Fresh Mint Flavor, Net Wt 0.6 OZ (17 g) Tube, Made in India, Dist. by Bob Barker Co. Inc., Fuquay-Varina, NC 27526, NDC 53247-132-02", "product_quantity": "391,680 Tubes", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20250424", "center_classification_date": "20250519", "report_date": "20250528", "code_info": "Lot B0009, B0017, Exp Date: 05/31/2026; Lot B0018, B0019, B0036, B0037, B0038, Exp Date: 06/30/2026; Lot B0049, Exp Date: 07/31/2026; B0063, Exp Date: 08/31/2026"}, {"status": "Ongoing", "city": "Columbus", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA209101"], "brand_name": ["HALOPERIDOL DECANOATE"], "generic_name": ["HALOPERIDOL DECANOATE"], "manufacturer_name": ["BluePoint Laboratories"], "product_ndc": ["68001-578", "68001-579", "68001-580", "68001-581", "68001-582"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR"], "substance_name": ["HALOPERIDOL DECANOATE"], "rxcui": ["859871", "1719803", "1719862"], "spl_id": ["048557ea-f859-f0f2-e063-6294a90af5ab"], "spl_set_id": ["f2d14406-2ad4-4c5b-9c24-a026f27b415d"], "package_ndc": ["68001-579-59", "68001-579-48", "68001-580-41", "68001-581-41", "68001-581-48", "68001-581-82", "68001-578-59", "68001-578-48", "68001-582-41"], "is_original_packager": [true], "upc": ["0368001578592", "0368001581417", "0368001579599", "0368001582414"], "unii": ["AC20PJ4101"]}, "product_type": "Drugs", "event_id": "96636", "recalling_firm": "Amerisource Health Services LLC", "address_1": "2550 John Glenn Ave Ste A", "address_2": "N/A", "postal_code": "43217-1188", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0368-2025", "product_description": "Haloperidol Decanoate Injection, 100 mg/mL*, 1 x 1 mL Single-Dose Vial,  Rx only, Manufactured by: Somerset Therapeutics Limited, #54/1, Boodhihal Village, Nelamangala, Bangalore - 562123, Karnataka, India, Manufactured for BluePoint Laboratories, NDC 68001-581-41.", "product_quantity": "14,189 vials", "reason_for_recall": "Lack of assurance of sterility. Bacterial contamination detected in some media fill units", "recall_initiation_date": "20250402", "center_classification_date": "20250418", "report_date": "20250430", "code_info": "A240482A, EXP 08/31/2026"}, {"status": "Ongoing", "city": "Ta. Kadi, District Mehsana", "state": "N/A", "country": "India", "classification": "Class II", "openfda": {"application_number": ["M017"], "brand_name": ["OPTIMV ANTI-ITCH"], "generic_name": ["BENZOCAINE, RESORCINOL"], "manufacturer_name": ["Pharmadel LLC"], "product_ndc": ["55758-300"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["BENZOCAINE", "RESORCINOL"], "rxcui": ["637518"], "spl_id": ["2734db1a-7a67-9504-e063-6394a90a274d"], "spl_set_id": ["e064940f-83d7-85b6-e053-2995a90aec92"], "package_ndc": ["55758-300-07", "55758-300-01"], "is_original_packager": [true], "nui": ["N0000185508", "N0000175629", "N0000184306", "M0000728"], "pharm_class_epc": ["Standardized Chemical Allergen [EPC]"], "pharm_class_pe": ["Increased Histamine Release [PE]", "Cell-mediated Immunity [PE]"], "pharm_class_cs": ["Allergens [CS]"], "unii": ["U3RSY48JW5", "YUL4LO94HK"], "upc": ["859424004206"]}, "product_type": "Drugs", "event_id": "96797", "recalling_firm": "KENIL HEALTHCARE PRIVATE LIMITED", "address_1": "Plot 319", "address_2": "Village Acharasan, Ankhol-Vamaj Road", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "DE and NC", "recall_number": "D-0427-2025", "product_description": "Optim V, Anti-Itch Cream, Benzocaine 20% & Resorcinol 3% - External analgesic, Net Wt. Peso Neto 1 oz (28g) Tube, Distributed by: Pharmadel LLC, New Castle, DE 19720, Made in India, NDC 55758-300-01, UPC 8 59424 00420 6.", "product_quantity": "6,372 Tubes", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20250424", "center_classification_date": "20250519", "report_date": "20250528", "code_info": "Lot SP24A, Exp: 09/30/2026"}, {"status": "Ongoing", "city": "Berlin", "state": "CT", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA203088"], "brand_name": ["DULOXETINE"], "generic_name": ["DULOXETINE HYDROCHLORIDE"], "manufacturer_name": ["Breckenridge Pharmaceutical, Inc."], "product_ndc": ["51991-746", "51991-747", "51991-748", "51991-750"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DULOXETINE HYDROCHLORIDE"], "rxcui": ["596926", "596930", "596934", "616402"], "spl_id": ["32327581-bdab-41ac-9adc-bf208e1c4e42"], "spl_set_id": ["caef6f50-1571-4ec7-8f8c-42b924d323ee"], "package_ndc": ["51991-746-06", "51991-746-90", "51991-746-05", "51991-747-33", "51991-747-90", "51991-747-10", "51991-748-33", "51991-748-90", "51991-748-10", "51991-750-33", "51991-750-90", "51991-750-05", "51991-750-10"], "is_original_packager": [true], "unii": ["9044SC542W"]}, "product_type": "Drugs", "event_id": "96707", "recalling_firm": "Breckenridge Pharmaceutical, Inc", "address_1": "15 Massirio Dr Ste 201", "address_2": "N/A", "postal_code": "06037-2352", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "US Nationwide.", "recall_number": "D-0388-2025", "product_description": "Duloxetine Delayed-Release Capsules USP, 30 mg, a.) 90-count bottles (NDC# 51991-747-90), b.) 1000-count bottles (NDC 51991-747-10), Rx Only, Manufactured by Towa Pharmaceutical Europe, S.L. Distributed by Breckenridge Pharmaceutical, Inc. Berkeley Heights, NJ 07922", "product_quantity": "343,344 bottles", "reason_for_recall": "CGMP Deviations: Presence of Nitrosamine Drug Substance Related Impurity above the proposed interim limit.", "recall_initiation_date": "20250414", "center_classification_date": "20250422", "report_date": "20250430", "code_info": "Lot #  230201C, exp. date 01/2026 230471C, exp. date 01/2026 230288C, exp. date 01/2026"}, {"status": "Ongoing", "city": "East Windsor", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA211817"], "brand_name": ["TESTOSTERONE CYPIONATE"], "generic_name": ["TESTOSTERONE CYPIONATE"], "manufacturer_name": ["Eugia US LLC"], "product_ndc": ["55150-276", "55150-277", "55150-278"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR"], "substance_name": ["TESTOSTERONE CYPIONATE"], "rxcui": ["835829", "835840", "2047882"], "spl_id": ["b622f795-00fa-48e3-8e4d-679c2ce28c6c"], "spl_set_id": ["f901e2b2-f143-4237-8e95-0d134585490b"], "package_ndc": ["55150-276-01", "55150-277-01", "55150-278-01"], "is_original_packager": [true], "upc": ["0355150276011", "0355150278015", "0355150277018"], "unii": ["M0XW1UBI14"]}, "product_type": "Drugs", "event_id": "96680", "recalling_firm": "Eugia US LLC", "address_1": "279 Princeton Hightstown Rd", "address_2": "", "postal_code": "08520-1401", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA", "recall_number": "D-0363-2025", "product_description": "Testosterone Cypionate Injection, USP, CIII, 200mg per mL, Rx only, 1mL Single-Dose Vial,  Distributed by Eugia US LLC, E. Windsor, NJ, Manufactured by: Eugia Specialties Limited, Telangana State, India, NDC 55150-277-01", "product_quantity": "36,816 vials", "reason_for_recall": "cGMP: complaints of crystals not redissolving into solution after warming and shaking the vials.", "recall_initiation_date": "20250410", "center_classification_date": "20250414", "report_date": "20250423", "code_info": "Lot #: 1TC24075A, Exp 11/30/2026.", "more_code_info": ""}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA090355"], "brand_name": ["THEOPHYLLINE"], "generic_name": ["THEOPHYLLINE"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "product_ndc": ["68462-356", "68462-380"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["THEOPHYLLINE ANHYDROUS"], "rxcui": ["313291", "348472"], "spl_id": ["aaa6684e-4eef-42a8-92b6-8f317e570903"], "spl_set_id": ["56fc2167-ceb6-4e3e-8ff7-5e400dfbd533"], "package_ndc": ["68462-380-01", "68462-380-05", "68462-356-01", "68462-356-05"], "is_original_packager": [true], "upc": ["0368462380017", "0368462356012"], "nui": ["N0000175790", "M0023046"], "pharm_class_epc": ["Methylxanthine [EPC]"], "pharm_class_cs": ["Xanthines [CS]"], "unii": ["0I55128JYK"]}, "product_type": "Drugs", "event_id": "96867", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0452-2025", "product_description": "Theophylline (Anhydrous) Extended-Release Tablets, 600 mg, 100 Tablets per bottle, Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited. Colvale-Bardez, Goa - 403513, India. Manufactured for: Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ 07430.  NDC: 68462-356-01", "product_quantity": "8,520 100-count bottles", "reason_for_recall": "OOS results reported for the Dissolution (by UV) test.", "recall_initiation_date": "20250515", "center_classification_date": "20250528", "report_date": "20250604", "code_info": "Lots: 19234121, 19234148, Exp Sep-30-25; Lots 19242881, 19242899, Exp Jun-30-26"}, {"status": "Ongoing", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["ANDA206880"], "brand_name": ["LEVETIRACETAM"], "generic_name": ["LEVETIRACETAM INJECTION"], "manufacturer_name": ["Dr.Reddy's Laboratories Inc"], "product_ndc": ["43598-635", "43598-636", "43598-637"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["LEVETIRACETAM"], "rxcui": ["1193358", "1193360", "1193362"], "spl_id": ["f5cfc6e1-79f3-bd25-5f66-9ea05bc47def"], "spl_set_id": ["0a9234b7-46b1-8e6c-a992-90f86cfb6e00"], "package_ndc": ["43598-635-52", "43598-635-10", "43598-636-52", "43598-636-10", "43598-637-52", "43598-637-10"], "is_original_packager": [true], "nui": ["N0000008486"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "unii": ["44YRR34555"]}, "product_type": "Drugs", "event_id": "96470", "recalling_firm": "Dr. Reddy's Laboratories, Inc.", "address_1": "107 College Rd E", "address_2": "", "postal_code": "08540-6623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0365-2025", "product_description": "Levetiracetam 0.75% in Sodium Chloride Injection 1,000 mg/100 mL (10 mg/mL), 1 x 100mL, Rx Only, Manufactured by: Gland Pharma Limited, Hyderabad, - 500 043 INDIA, Distributor: Dr. Reddy's Laboratories Inc., Princeton, NJ 08540, NDC 43598-636-52", "product_quantity": "4,010 bags", "reason_for_recall": "LABELING: LABEL MIX-UP: The infusion bag is incorrectly labeled as Levetiracetam in 0.82% Sodium Chloride Injection 500 mg/100 mL, while the aluminum overwrap packaging correctly identifies the product as Levetiracetam in 0.75% Sodium Chloride Injection 1,000 mg/100 mL.", "recall_initiation_date": "20250313", "center_classification_date": "20250416", "report_date": "20250423", "code_info": "Lot: A1540076, Exp 08/31/2026", "more_code_info": ""}, {"status": "Ongoing", "city": "Tempe", "state": "AZ", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "96735", "recalling_firm": "SAINI TRADE INC", "address_1": "1405 N Scottsdale Rd", "address_2": "", "postal_code": "85288-1714", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0465-2025", "product_description": "ELECTRO BUZZ, Dietary Supplement, 10 capsules per box, Distributed By: Health Fixer, Tempe, AZ 85288, UPC B0DK68LF6J.", "product_quantity": "300 boxes", "reason_for_recall": "Marketed without an Approved NDA/ANDA: Laboratory analysis found the product to be tainted with undeclared chloropretadalafil, propoxyphenylsildenafil, and sildenafil.", "recall_initiation_date": "20250414", "center_classification_date": "20250611", "report_date": "20250618", "code_info": "All lots Lot #: KT-1ST-43-01-07/2024, Exp. 10/15/2026", "more_code_info": ""}, {"status": "Ongoing", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA210221"], "brand_name": ["CEPHALEXIN"], "generic_name": ["CEPHALEXIN"], "manufacturer_name": ["Ascend Laboratories, LLC"], "product_ndc": ["67877-544", "67877-545"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CEPHALEXIN"], "rxcui": ["309110", "309113"], "spl_id": ["84f07b4a-a15e-41cb-af85-e110c5cf342e"], "spl_set_id": ["bb28751c-bd1b-4e7f-8271-a14c1b4314e3"], "package_ndc": ["67877-544-88", "67877-544-68", "67877-545-88", "67877-545-68"], "is_original_packager": [true], "unii": ["OBN7UDS42Y"]}, "product_type": "Drugs", "event_id": "96912", "recalling_firm": "Ascend Laboratories, LLC", "address_1": "339 Jefferson Rd Ste 101", "address_2": "", "postal_code": "07054-3707", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0469-2025", "product_description": "Cephalexin for Oral Suspension, USP, 125 mg per 5 mL, 200 mL (when mixed), Rx Only, Manufactured by: Alkem Laboratories Ltd., India, Distributed by: Ascent Laboratories, LLC, Parsippany, NJ 07054, NDC 67877-544-68", "product_quantity": "10,620 - 200 mL bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications An out-of-specification result was observed in the related substance test at the sixth month of stability analysis.    The individual impurity was identified to be Cephalexin Glucose Adduct.", "recall_initiation_date": "20250523", "center_classification_date": "20250612", "report_date": "20250618", "code_info": "Lot #: 23142343, Exp Date: 6/30/2025; 23143526, Exp Date: 9/30/2025; 23144036, Exp Date: 10/31/2025; 23144269, Exp Date: 11/30/2025; Lot 24140027, Exp Date: 12/31/2025; 24144282, Exp Date: 10/31/2026", "more_code_info": ""}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA205268"], "brand_name": ["PROPAFENONE HYDROCHLORIDE"], "generic_name": ["PROPAFENONE HYDROCHLORIDE"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "product_ndc": ["68462-408", "68462-409", "68462-410"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["PROPAFENONE HYDROCHLORIDE"], "rxcui": ["861156", "861164", "861171"], "spl_id": ["064ec508-4c51-41fa-929f-0abe45b4779b"], "spl_set_id": ["d818af31-2535-4595-82fe-fd7abf66fd6c"], "package_ndc": ["68462-408-60", "68462-409-60", "68462-410-60"], "is_original_packager": [true], "upc": ["0368462409602", "0368462410608", "0368462408605"], "unii": ["33XCH0HOCD"]}, "product_type": "Drugs", "event_id": "96474", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0316-2025", "product_description": "Propafenone Hydrochloride Extended-Release Capsules 325mg, 60-count bottle, Rx Only Manufactured by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh 454775, India, Manufactured for: Glenmark Pharmaceuticals Inc. USA, Mahwah, NJ 07430. NDC# 68462-409-60", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20250313", "center_classification_date": "20250408", "report_date": "20250416", "code_info": "Lot #  17230767, exp. date Mar-25"}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA078251"], "brand_name": ["CARVEDILOL"], "generic_name": ["CARVEDILOL"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "product_ndc": ["68462-162", "68462-163", "68462-164", "68462-165"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CARVEDILOL"], "rxcui": ["200031", "200032", "200033", "686924"], "spl_id": ["5f5b2d20-cc2a-4e91-b2b9-260e7438ab2c"], "spl_set_id": ["c4a21f67-7812-4634-beba-f8e85c63c5f2"], "package_ndc": ["68462-162-60", "68462-162-01", "68462-162-18", "68462-162-05", "68462-162-10", "68462-163-60", "68462-163-01", "68462-163-18", "68462-163-05", "68462-163-10", "68462-164-60", "68462-164-01", "68462-164-18", "68462-164-05", "68462-164-10", "68462-165-60", "68462-165-01", "68462-165-18", "68462-165-05", "68462-165-10"], "is_original_packager": [true], "upc": ["0368462162019", "0368462163016", "0368462164013", "0368462165010"], "nui": ["N0000000099", "N0000009923", "N0000009924", "N0000175553", "N0000175556"], "pharm_class_moa": ["Adrenergic alpha-Antagonists [MoA]", "Adrenergic beta1-Antagonists [MoA]", "Adrenergic beta2-Antagonists [MoA]"], "pharm_class_epc": ["alpha-Adrenergic Blocker [EPC]", "beta-Adrenergic Blocker [EPC]"], "unii": ["0K47UL67F2"]}, "product_type": "Drugs", "event_id": "96861", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0448-2025", "product_description": "Carvedilol Tablets USP 3.125mg Tablets  a.)100-count bottle (NDC 68462-162-01), b.) 500-count bottle (NDC 68462-162-05),  Rx Only, Manufactured by: Glenmark Pharmaceuticals Ltd., Manufactured for: Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ 07430.", "product_quantity": "[100 Tablet Bottles] 59,952 bottles; [500 Tablet Bottles] 155,976 bottles", "reason_for_recall": "CGMP Deviations; presence 'N-Nitroso Carvedilol I' Impurity above the recommended acceptable intake limit", "recall_initiation_date": "20250228", "center_classification_date": "20250528", "report_date": "20250604", "code_info": "[100-Count Bottles]   Lot 19231450, Exp Mar-25, 19233345, Exp Jul-25; Lot 19234275, Exp Sep-25; Lot 19240280, Exp DEC-25  [500-Count Bottles]   Lot 19231450, 19231464, 19231471, 19231493, Exp Mar-25, 19232083, 19232103 Exp Apr-25, 19232658, Exp Jun-25; Lot 19233328, 19233343, 19233344, 19233345, Exp Jul-25; Lot 19234275, Exp Sep-25; Lots 19234843,  19235039, Exp Nov-25; Lots 19240280, 19240296, Dec-25"}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA203503"], "brand_name": ["VORICONAZOLE"], "generic_name": ["VORICONAZOLE"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "product_ndc": ["68462-572", "68462-573"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["VORICONAZOLE"], "rxcui": ["349434", "349435"], "spl_id": ["1c47b796-6b3e-4321-86f6-f51fbf9a39fb"], "spl_set_id": ["4cbac6ad-0faa-4181-a830-27a9f1536b7a"], "package_ndc": ["68462-572-30", "68462-572-90", "68462-572-13", "68462-573-30", "68462-573-90", "68462-573-13"], "is_original_packager": [true], "upc": ["0368462573303"], "nui": ["N0000175487", "M0002083", "N0000182141", "N0000182140", "N0000185504"], "pharm_class_epc": ["Azole Antifungal [EPC]"], "pharm_class_cs": ["Azoles [CS]"], "pharm_class_moa": ["Cytochrome P450 3A4 Inhibitors [MoA]", "Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 2C9 Inhibitors [MoA]"], "unii": ["JFU09I87TR"]}, "product_type": "Drugs", "event_id": "96474", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0319-2025", "product_description": "Voriconazole Tablets 50mg, 30-count bottle, Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh 454775, India, Manufactured for: Glenmark Pharmaceuticals Inc. USA, Mahwah, NJ 07430. NDC# 68462-572-30.", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20250313", "center_classification_date": "20250408", "report_date": "20250416", "code_info": "Lot # 17231045, exp. date Apr-25"}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA203480"], "brand_name": ["COLESEVELAM HYDROCHLORIDE"], "generic_name": ["COLESEVELAM HYDROCHLORIDE"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "product_ndc": ["68462-433"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["COLESEVELAM HYDROCHLORIDE"], "rxcui": ["866910"], "spl_id": ["836cbdcd-e2b0-468f-8aff-32ecd9760e78"], "spl_set_id": ["845b8661-0aa9-418f-a496-df3d7a3130ff"], "package_ndc": ["68462-433-90", "68462-433-18"], "is_original_packager": [true], "upc": ["0368462433188"], "unii": ["P4SG24WI5Q"]}, "product_type": "Drugs", "event_id": "96474", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0340-2025", "product_description": "Colesvelam Hydrocholoride Tablets 625mg, 180-count bottle, Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh 454775, India, Manufactured for: Glenmark Pharmaceuticals Inc. USA, Mahwah, NJ 07430. NDC# 68462-433-18", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20250313", "center_classification_date": "20250408", "report_date": "20250416", "code_info": "Lot #  17240669, exp. date Mar-26 17240876, exp. date Apr-26 17240883, exp. date May-26 17240909, exp. date May-26 17240914, exp. date May-26 17240927, exp. date May-26"}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA205994"], "brand_name": ["SAXAGLIPTIN"], "generic_name": ["SAXAGLIPTIN"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "product_ndc": ["68462-726", "68462-727"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["SAXAGLIPTIN HYDROCHLORIDE"], "rxcui": ["858036", "858042"], "spl_id": ["e286ffd4-c598-47fb-af06-2e15f7e6f99f"], "spl_set_id": ["e286ffd4-c598-47fb-af06-2e15f7e6f99f"], "package_ndc": ["68462-726-30", "68462-726-90", "68462-726-05", "68462-727-30", "68462-727-90", "68462-727-05", "68462-727-14"], "is_original_packager": [true], "upc": ["0368462726907"], "unii": ["Z8J84YIX6L"]}, "product_type": "Drugs", "event_id": "96474", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0332-2025", "product_description": "Saxagliptin Tablets 5mg, a). 30-count bottle (NDC# 68462-727-30) b.) 90-count bottle ( 68462-727-90), Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh 454775, India, Manufactured for: Glenmark Pharmaceuticals Inc. USA, Mahwah, NJ 07430.", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20250313", "center_classification_date": "20250408", "report_date": "20250416", "code_info": "Lot #  17232460, exp. date Nov-25 17232460, exp. date Nov-25 17241194, exp. date Jun-26 17241194, exp. date Jun-26"}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA206391"], "brand_name": ["NITROGLYCERIN"], "generic_name": ["NITROGLYCERIN"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "product_ndc": ["68462-638", "68462-639", "68462-640"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["SUBLINGUAL"], "substance_name": ["NITROGLYCERIN"], "rxcui": ["198038", "198039", "198040"], "spl_id": ["91f10148-6ba2-41ef-b454-0f22741a77d3"], "spl_set_id": ["fa789d65-9407-4965-bd06-4457444b42be"], "package_ndc": ["68462-638-01", "68462-639-01", "68462-639-25", "68462-639-45", "68462-640-01"], "is_original_packager": [true], "upc": ["0368462638019", "0368462639016", "0368462640012"], "nui": ["N0000175415", "M0014874", "N0000009909"], "pharm_class_epc": ["Nitrate Vasodilator [EPC]"], "pharm_class_cs": ["Nitrates [CS]"], "pharm_class_pe": ["Vasodilation [PE]"], "unii": ["G59M7S0WS3"]}, "product_type": "Drugs", "event_id": "96474", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0324-2025", "product_description": "Nitroglycerin  Sublingual Tablets 0.4MG 100-count carton, Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh 454775, India, Manufactured for: Glenmark Pharmaceuticals Inc. USA, Mahwah, NJ 07430. NDC# 68462-639-45.", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20250313", "center_classification_date": "20250408", "report_date": "20250416", "code_info": "Lot #  17232024, exp. date Aug-25 17232071, exp. date Sep-25 17232072, exp. date Sep-25"}, {"status": "Ongoing", "city": "Saint Louis", "state": "MO", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M018"], "brand_name": ["ARTIFICIAL TEARS"], "generic_name": ["ARTIFICIAL TEARS"], "manufacturer_name": ["AvPAK"], "product_ndc": ["50268-043"], "product_type": ["HUMAN OTC DRUG"], "route": ["OPHTHALMIC"], "substance_name": ["DEXTRAN 70", "GLYCERIN", "HYPROMELLOSES"], "rxcui": ["900138"], "spl_id": ["334b4087-9641-b765-e063-6394a90a28a6"], "spl_set_id": ["f18bebf2-1936-658f-e053-2a95a90a5012"], "package_ndc": ["50268-043-15"], "is_original_packager": [true], "nui": ["N0000184175", "N0000009361", "N0000010288", "N0000185370", "N0000175629", "N0000184306", "N0000185001", "M0000728", "M0009417"], "pharm_class_epc": ["Plasma Volume Expander [EPC]", "Non-Standardized Chemical Allergen [EPC]"], "pharm_class_pe": ["Increased Intravascular Volume [PE]", "Increased Histamine Release [PE]", "Cell-mediated Immunity [PE]", "Increased IgG Production [PE]"], "pharm_class_moa": ["Osmotic Activity [MoA]"], "pharm_class_cs": ["Allergens [CS]", "Glycerol [CS]"], "unii": ["7SA290YK68", "PDC6A3C0OX", "3NXW29V3WO"]}, "product_type": "Drugs", "event_id": "96741", "recalling_firm": "BRS Analytical Services, LLC", "address_1": "11697 Lakeside Crossing Ct", "address_2": "N/A", "postal_code": "63146-8606", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0404-2025", "product_description": "Artificial Tears Ophthalmic Solution, Dextran 70.01%/Glycerin 0.2%/Hypromellose 0.3% (Eye Lubricants) Lubricant Eye Drops, STERILE, 0.5 FL OZ (15 mL) per dropper bottle, Distributed by: AvKARE, Pulaski, TN 38478, NDC: 50268-043-15.", "product_quantity": "13,872 cases (24 cartons per case)", "reason_for_recall": "cGMP deviations and lack of assurance of sterility.", "recall_initiation_date": "20250423", "center_classification_date": "20250506", "report_date": "20250514", "code_info": "Lot, expiry:  Lot 126, exp 10/26/25; Lot 127, exp 10/30/25; Lot 128, exp 11/02/25; Lot 129, exp 11/06/25; Lot 162, exp 5/09/26; Lot 163, exp 5/14/26; Lot 164, exp 5/20/26; Lot 165, exp 5/23/26; Lot 166, exp 5/29/26; Lot 167, exp 6/03/26; Lot 168, exp 6/06/26; Lot 169, exp 6/10/26; Lot 170, exp 6/13/26; Lot 193, exp 10/07/26; Lot 194, exp 10/10/26; Lot 195, exp 10/14/26; Lot 196, exp 10/17/26; Lot 197, exp 10/21/26; Lot 198, exp 10/24/26; Lot 199, exp 10/30/26.", "more_code_info": ""}, {"status": "Ongoing", "city": "ISELIN", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA216436"], "brand_name": ["ATORVASTATIN CALCIUM"], "generic_name": ["ATORVASTATIN CALCIUM"], "manufacturer_name": ["Biocon Pharma Inc."], "product_ndc": ["70377-077", "70377-078", "70377-079", "70377-080"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ATORVASTATIN CALCIUM TRIHYDRATE"], "rxcui": ["259255", "617310", "617311", "617312"], "spl_id": ["72b8b3f5-4658-80af-655c-87ce7966a5e6"], "spl_set_id": ["5b839619-1805-c227-91bf-182f5b966ba4"], "package_ndc": ["70377-077-11", "70377-077-13", "70377-077-12", "70377-078-11", "70377-078-13", "70377-078-12", "70377-079-11", "70377-079-12", "70377-079-13", "70377-080-11", "70377-080-12", "70377-080-13"], "is_original_packager": [true], "upc": ["0370377080111"], "unii": ["48A5M73Z4Q"]}, "product_type": "Drugs", "event_id": "96496", "recalling_firm": "BIOCON PHARMA INC", "address_1": "485 HWY 1 (S)", "address_2": "", "postal_code": "08830", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "", "distribution_pattern": "U.S.A. nationwide", "recall_number": "D-0306-2025", "product_description": "Atorvastatin Calcium Tablets USP 40 mg, 1000-count bottle, Rx Only, Manufactured for: Biocon Pharma Inc., Iselin, NJ 08830-3009 USA, Manufactured by: Recipharm Pharmaservices PVT, Ltd Bengaluru, INDIA -562-123, NDC 70377-079-13", "product_quantity": "2184 bottles", "reason_for_recall": "Failed dissolution specifications: lower than specifications", "recall_initiation_date": "20250317", "center_classification_date": "20250328", "report_date": "20250409", "code_info": "Lot#: AVC24035, Exp 03/31/26", "more_code_info": ""}, {"status": "Ongoing", "city": "Aurangabad, Maharashtra State", "state": "N/A", "country": "India", "classification": "Class II", "openfda": {"application_number": ["ANDA077259"], "brand_name": ["TIMOLOL MALEATE"], "generic_name": ["TIMOLOL MALEATE"], "manufacturer_name": ["Rising Pharma Holdings, Inc."], "product_ndc": ["64980-513", "64980-514"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["OPHTHALMIC"], "substance_name": ["TIMOLOL MALEATE"], "rxcui": ["1923428", "1992303"], "spl_id": ["7ef88352-6fe4-48a4-b72b-15419d3ed051"], "spl_set_id": ["2ed21930-1e05-46de-8acd-cb6f4798a7fa"], "package_ndc": ["64980-513-05", "64980-513-01", "64980-513-15", "64980-514-05", "64980-514-01", "64980-514-15"], "is_original_packager": [true], "upc": ["0364980513050", "0364980514057"], "unii": ["P8Y54F701R"]}, "product_type": "Drugs", "event_id": "96740", "recalling_firm": "FDC Limited", "address_1": "B-8 MIDC Industrial Area", "address_2": "Waluj District", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0403-2025", "product_description": "Timolol Maleate Ophthalmic Solution USP, 0.5%, Sterile, 10mL bottles, Rx only, Manufactured by: FDC Limited, Waluj, Aurangabad, Maharashtra, India, Distributed by: Rising Pharmaceuticals Inc, New Jersey, NDC 64980-514-01.", "product_quantity": "60428 bottles", "reason_for_recall": "Defective Container: Unable to get the solution out of the bottle as the spike of the cap was lodged in the nozzle of the product bottle.", "recall_initiation_date": "20250418", "center_classification_date": "20250505", "report_date": "20250514", "code_info": "Lot #: 083I098, Exp. Date 08/31/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Melville", "state": "NY", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "96290", "recalling_firm": "Ascent Consumer Products Inc.", "address_1": "105 Baylis Rd", "address_2": "N/A", "postal_code": "11747-3833", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the US.", "recall_number": "D-0299-2025", "product_description": "SinuCleanse Soft Tip Squeeze Bottle Nasal Wash System (sodium bicarbonate USP 700 mg and sodium chloride USP 2300 mg), 30-count All Natural USP Grade Saline Packets and 1 Soft tip Squeeze Bottle, Net WT 0.1OZ (3g) each, Distributed by Ascent Consumer Products Inc., Melville, NY 11747, UPC 6 46011 00104 1", "product_quantity": "4,176 cartons", "reason_for_recall": "Microbial Contamination of Non-Sterile Products: Bacterial contamination with Staphylococcus aureus", "recall_initiation_date": "20250128", "center_classification_date": "20250325", "report_date": "20250402", "code_info": "Lot# 024122661Al, Exp Date 12/2027"}, {"status": "Ongoing", "city": "La Vergne", "state": "TN", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA203016"], "brand_name": ["TOLTERODINE TARTRATE"], "generic_name": ["TOLTERODINE"], "manufacturer_name": ["Major Pharmaceuticals"], "product_ndc": ["0904-6593", "0904-6592"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["TOLTERODINE TARTRATE"], "rxcui": ["855182", "855189"], "spl_id": ["29bf12b7-e530-4337-a021-ca7138b39d78"], "spl_set_id": ["da9423b5-00ab-46fc-8959-3db3c0a0bc6d"], "package_ndc": ["0904-6592-04", "0904-6593-04"], "original_packager_product_ndc": ["13668-189", "13668-190"], "unii": ["5T619TQR3R"]}, "product_type": "Drugs", "event_id": "96416", "recalling_firm": "The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories", "address_1": "341 Mason Rd", "address_2": "", "postal_code": "37086-3606", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0304-2025", "product_description": "Tolterodine Tartrate Extended-Release Capsules, 2 mg, 30 Capsules (3 x 10) Unit Dose carton, Rx only, Packaged and Distributed by: Major Pharmaceuticals, Indianapolis, IN 46268 USA, NDC 0904-6592-04.", "product_quantity": "224 cartons", "reason_for_recall": "Failed Dissolution Specifications: Out of specification results obtained during routine stability testing for dissolution.", "recall_initiation_date": "20250304", "center_classification_date": "20250328", "report_date": "20250409", "code_info": "Lot# T05393, Exp. Date: 09/30/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA078251"], "brand_name": ["CARVEDILOL"], "generic_name": ["CARVEDILOL"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "product_ndc": ["68462-162", "68462-163", "68462-164", "68462-165"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CARVEDILOL"], "rxcui": ["200031", "200032", "200033", "686924"], "spl_id": ["5f5b2d20-cc2a-4e91-b2b9-260e7438ab2c"], "spl_set_id": ["c4a21f67-7812-4634-beba-f8e85c63c5f2"], "package_ndc": ["68462-162-60", "68462-162-01", "68462-162-18", "68462-162-05", "68462-162-10", "68462-163-60", "68462-163-01", "68462-163-18", "68462-163-05", "68462-163-10", "68462-164-60", "68462-164-01", "68462-164-18", "68462-164-05", "68462-164-10", "68462-165-60", "68462-165-01", "68462-165-18", "68462-165-05", "68462-165-10"], "is_original_packager": [true], "upc": ["0368462162019", "0368462163016", "0368462164013", "0368462165010"], "nui": ["N0000000099", "N0000009923", "N0000009924", "N0000175553", "N0000175556"], "pharm_class_moa": ["Adrenergic alpha-Antagonists [MoA]", "Adrenergic beta1-Antagonists [MoA]", "Adrenergic beta2-Antagonists [MoA]"], "pharm_class_epc": ["alpha-Adrenergic Blocker [EPC]", "beta-Adrenergic Blocker [EPC]"], "unii": ["0K47UL67F2"]}, "product_type": "Drugs", "event_id": "96861", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0449-2025", "product_description": "Carvedilol Tablets USP 6.25 mg, a.)100-count bottle (NDC 68462-163-01), b.) 500-count bottle (NDC 68462-163-05) Rx Only, Manufactured by: Glenmark Pharmaceuticals Ltd., Manufactured for: Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ 07430.", "product_quantity": "[100 Tablet Bottles] 90,000 bottles; [500 Tablet Bottles] 324,288 bottles", "reason_for_recall": "CGMP Deviations; presence 'N-Nitroso Carvedilol I' Impurity above the recommended acceptable intake limit", "recall_initiation_date": "20250228", "center_classification_date": "20250528", "report_date": "20250604", "code_info": "[100-Count Bottles]    Lot 19231618, exp Mar-25; 19232064, exp Apr-25; 19232324, May-25; 19233369, Exp Jul-25;  Lot 19234162, Exp Sep-25; Lot 19240543, Exp Jan-26   [500-Count Bottles]   Lots 19231174, 19231199, 19231164, Exp Feb-25, 19231517,19231527, 19231566,19231568,19231595, 19231618,19231634,19231638, 19231448, Exp Mar-25, 19232043,19232051,19232064, Apr-25, 19232322, 19232324, 19232365, 19232380, 19232389, Exp May-25; Lots 19232736, 19232743, 19232746, 19232756, 19232757, Exp Jun-25; Lots 19233369, 19233371, 19233405, 19233416, Exp Jul-25; Lots 19234162, 19234183, 19234192, 19234204, 19234223, 19234243, 19234263, 19234165, 19234242, Exp Sep-25; Lots 19234743, 19234774, 19234993, Exp Nov-25; Lots 19240223, 19240203, 19240211, 19240214, 19240247, 19240249, 19240272, 19240319, Exp Dec-25; Lot 19240543, Exp Jan-26"}, {"status": "Ongoing", "city": "Bridgewater", "state": "NJ", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["ANDA216605"], "brand_name": ["ROPIVACAINE HYDROCHLORIDE"], "generic_name": ["ROPIVACAINE HYDROCHLORIDE"], "manufacturer_name": ["Amneal Pharmaceuticals LLC"], "product_ndc": ["70121-1732", "70121-1733", "70121-1734", "70121-1735"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["EPIDURAL", "INFILTRATION", "PERINEURAL"], "substance_name": ["ROPIVACAINE HYDROCHLORIDE"], "rxcui": ["1734347", "1734355", "1734479", "1734481"], "spl_id": ["aa7176ac-f262-4470-a4de-60e288c05ac3"], "spl_set_id": ["da1ce22b-6a8e-40a2-afbb-011fa3ed3a8b"], "package_ndc": ["70121-1732-9", "70121-1732-3", "70121-1733-9", "70121-1733-3", "70121-1734-7", "70121-1734-3", "70121-1735-7", "70121-1735-3", "70121-1734-1"], "is_original_packager": [true], "upc": ["0370121173533", "0370121173434", "0370121173335", "0370121173311", "0370121173410", "0370121173519", "0370121173397", "0370121173298", "0370121173212"], "unii": ["V910P86109"]}, "product_type": "Drugs", "event_id": "96648", "recalling_firm": "Amneal Pharmaceuticals, LLC", "address_1": "400 Crossing Blvd Fl 3", "address_2": "N/A", "postal_code": "08807-2863", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0402-2025", "product_description": "Ropivacaine Hydrochloride Injection, USP, 0.5%, 500 mg per 100 mL (5mg/mL), Manufactured by: Amneal Pharmaceuticals Pvt. Ltd., Mehsana, India,  , Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807 NDC 70121-1734-1 (bag); NDC 70121-1734-3 (box)", "product_quantity": "62 (12x100mL) bags", "reason_for_recall": "Presence of Particulate Matter", "recall_initiation_date": "20250417", "center_classification_date": "20250505", "report_date": "20250514", "code_info": "Lot #'s: AL240003, AL240004, Exp.: 01/31/2026", "more_code_info": ""}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA218311"], "brand_name": ["ACETAMINOPHEN, IBUPROFEN"], "generic_name": ["ACETAMINOPHEN, IBUPROFEN"], "manufacturer_name": ["GLENMARK THERAPEUTICS INC., USA"], "product_ndc": ["72657-157"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["ACETAMINOPHEN", "IBUPROFEN"], "rxcui": ["2387532"], "spl_id": ["80b301bb-8889-4fef-8523-afcb94c0f5fd"], "spl_set_id": ["57a8dc2b-a3bc-49fa-b605-2330155bdbff"], "package_ndc": ["72657-157-18", "72657-157-36", "72657-157-72", "72657-157-74", "72657-157-76", "72657-157-20", "72657-157-05"], "is_original_packager": [true], "upc": ["0372657157742"], "nui": ["N0000000160", "M0001335", "N0000175722"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]"], "unii": ["362O9ITL9D", "WK2XYI10QM"]}, "product_type": "Drugs", "event_id": "96474", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0347-2025", "product_description": "Acetaminophen and Ibuprofen (NSAID) Tablets, 250 mg/125 mg a). 144-count packets (NDC# 72657-157-74), b). 216-count packets( 72657-157-76),Distributed by: Glenmark Therapeutics Inc., USA, Mahwah, NJ 07430, Product of India", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20250313", "center_classification_date": "20250408", "report_date": "20250416", "code_info": "Lot #  17241302, exp. date Jul-26 Amazon & Walmart 17241140, exp. date Jul-26 Amazon & Walmart 17241141, exp. date Jul-26 Amazon & Walmart"}, {"status": "Ongoing", "city": "Lakewood", "state": "CO", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96792", "recalling_firm": "BSO LLC", "address_1": "12860 W Cedar Dr Ste 211", "address_2": "N/A", "postal_code": "80228-1971", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0412-2025", "product_description": "TESTOSTERONE PELLET 100 mg (with Cholesterol </=4%), 1 Pellet for Subcutaneous Use, This is a Compounded Drug, Not for Resale, RX or Office Use Only, Belmar Select Outsources, 12860 W. Cedar Drive #211, Lakewood, CO 80228, NDC: 70168-0101-01", "product_quantity": "2,762 vials", "reason_for_recall": "Presence of Particulate Matter: Glass particles were found in pellet vials.", "recall_initiation_date": "20250428", "center_classification_date": "20250506", "report_date": "20250514", "code_info": "Lot 20250102@6, exp 12/11/2025; Lot 20250130@4, exp 1/22/2026", "more_code_info": ""}, {"status": "Ongoing", "city": "Chattanooga", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96552", "recalling_firm": "Chattem Inc", "address_1": "1715 W 38th St", "address_2": "", "postal_code": "37409-1248", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "", "distribution_pattern": "Nationwide.", "recall_number": "D-0362-2025", "product_description": "Unisom, SleepMinis, Diphenhydramine HCl, Mini-Capsules, 25 mg, 60 Mini-Capsules bottles, Dist. by Chattem, Inc., P.O. Box 2219, Chattanooga, TN 37409-0219, USA, UPC 0 41167 00670 2", "product_quantity": "129,240 bottles", "reason_for_recall": "CGMP Deviations; detection of Nitrosamine Drug Substance-Related Impurities (NDSRI), N-nitroso-desmethyl-diphenhydramine (n-dph), above the FDA Recommended Intake Limit", "recall_initiation_date": "20250326", "center_classification_date": "20250411", "report_date": "20250423", "code_info": "LOT 22L603, EXP: Oct 2025; LOT 378999, EXP: Feb 2027", "more_code_info": ""}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA205006"], "brand_name": ["LACOSAMIDE"], "generic_name": ["LACOSAMIDE"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc. USA"], "product_ndc": ["68462-678", "68462-679", "68462-680", "68462-681"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LACOSAMIDE"], "rxcui": ["809987", "809992", "809996", "810000"], "spl_id": ["a65056ce-b6e9-4bed-adbd-98052a2e705e"], "spl_set_id": ["df1d2e6a-6129-49c9-b2c1-0fdf73f38b9c"], "package_ndc": ["68462-678-30", "68462-678-60", "68462-678-10", "68462-679-30", "68462-679-60", "68462-679-10", "68462-680-30", "68462-680-60", "68462-680-10", "68462-681-30", "68462-681-60", "68462-681-10"], "is_original_packager": [true], "upc": ["0368462680605", "0368462681602"], "nui": ["N0000008486"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "unii": ["563KS2PQY5"]}, "product_type": "Drugs", "event_id": "96474", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0330-2025", "product_description": "Lacosamide Tablets, 100mg , 60-count bottle, Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh 454775, India, Manufactured for: Glenmark Pharmaceuticals Inc. USA, Mahwah, NJ 07430. NDC# 68462-679-60", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20250313", "center_classification_date": "20250408", "report_date": "20250416", "code_info": "Lot #  17232533, exp. date Nov-25 17232534, exp. date Nov-25 17240606, exp. date Mar-26 17240619, exp. date Mar-26 17240911, exp. date May-26 17240912, exp. date May-26 17241121, exp. date Jun-26 17241124, exp. date Jun-26"}, {"status": "Ongoing", "city": "Ta. Kadi, District Mehsana", "state": "N/A", "country": "India", "classification": "Class II", "openfda": {"application_number": ["M017"], "brand_name": ["ARTRIDON"], "generic_name": ["MENTHOL, METHYL SALICYLATE"], "manufacturer_name": ["Pharmadel LLC"], "product_ndc": ["55758-030"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["MENTHOL, UNSPECIFIED FORM", "METHYL SALICYLATE"], "spl_id": ["25a37e66-e7e1-90bc-e063-6394a90ae964"], "spl_set_id": ["73572156-4cce-0669-e053-2991aa0aaecc"], "package_ndc": ["55758-030-05"], "is_original_packager": [true], "unii": ["L7T10EIP3A", "LAV5U5022Y"], "upc": ["810096771513"]}, "product_type": "Drugs", "event_id": "96797", "recalling_firm": "KENIL HEALTHCARE PRIVATE LIMITED", "address_1": "Plot 319", "address_2": "Village Acharasan, Ankhol-Vamaj Road", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "DE and NC", "recall_number": "D-0421-2025", "product_description": "Artridon Glucosamine (menthol 2% and Methyl Salicylate 15% - Topical Analgesic), for arthritis joint pain relief, 5 oz (142g) Tube, Dist by/por: Pharmadel LLC, New Castle, DE, 19720, Made in India, NDC 55758-030-05, UPC 8 10096 77151 3.", "product_quantity": "9,984 Tubes", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20250424", "center_classification_date": "20250519", "report_date": "20250528", "code_info": "Lot SP25A, Exp Date: 09/30/2026"}, {"status": "Ongoing", "city": "Ta. Kadi, District Mehsana", "state": "N/A", "country": "India", "classification": "Class II", "openfda": {"application_number": ["M017"], "brand_name": ["RAPIDOL"], "generic_name": ["HYDROCORTISONE"], "manufacturer_name": ["Pharmadel LLC"], "product_ndc": ["55758-420"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["HYDROCORTISONE"], "rxcui": ["106258"], "spl_id": ["25a3aeec-2ce5-6614-e063-6294a90a2ae5"], "spl_set_id": ["19a1f1e2-bc6b-7153-e063-6294a90ab115"], "package_ndc": ["55758-420-02"], "is_original_packager": [true], "nui": ["N0000175576", "N0000175450"], "pharm_class_epc": ["Corticosteroid [EPC]"], "pharm_class_moa": ["Corticosteroid Hormone Receptor Agonists [MoA]"], "unii": ["WI4X0X7BPJ"], "upc": ["810096771582"]}, "product_type": "Drugs", "event_id": "96797", "recalling_firm": "KENIL HEALTHCARE PRIVATE LIMITED", "address_1": "Plot 319", "address_2": "Village Acharasan, Ankhol-Vamaj Road", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "DE and NC", "recall_number": "D-0428-2025", "product_description": "Rapidol Maximum Strength, Hydrocortisone 1% Anti-Itch Cream, NET WT 2 oz (60g) Tube, Distributed by: Pharmadel LLC, New Castle, DE, 19720, NDC 55758-420-02, UPC 8 10096 77158 2.", "product_quantity": "10,000 Tubes", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20250424", "center_classification_date": "20250519", "report_date": "20250528", "code_info": "Lot SP26A, Exp: 09/30/2026"}, {"status": "Ongoing", "city": "Bengaluru", "state": "N/A", "country": "India", "classification": "Class II", "openfda": {"application_number": ["ANDA207522"], "brand_name": ["METHOCARBAMOL"], "generic_name": ["METHOCARBAMOL"], "manufacturer_name": ["Somerset Therapeutics, LLC"], "product_ndc": ["70069-101"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR", "INTRAVENOUS"], "substance_name": ["METHOCARBAMOL"], "rxcui": ["238175"], "spl_id": ["dd175ad9-9f83-4ef1-b745-65e44f5e12c4"], "spl_set_id": ["68dd9c24-4d41-48be-9f54-fceb787bb443"], "package_ndc": ["70069-101-25", "70069-101-10", "70069-101-05"], "is_original_packager": [true], "upc": ["0370069101018", "0370069101100", "0370069101254", "0370069101056"], "nui": ["N0000175730", "N0000175737"], "pharm_class_pe": ["Centrally-mediated Muscle Relaxation [PE]"], "pharm_class_epc": ["Muscle Relaxant [EPC]"], "unii": ["125OD7737X"]}, "product_type": "Drugs", "event_id": "96569", "recalling_firm": "Somerset Therapeutics Private Limited", "address_1": "54/1 Budihal Village", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0354-2025", "product_description": "Methocarbamol Injection USP\t1,000 mg/10 mL (100 mg/mL), 10 mL Single Dose Vial, Rx Only, Manufactured for: Somerset Therapeutics, LLC, Somerset, NJ 08873, NDC 70069-101-25 (immediate carton) and 70069-101-05 (5x10 mL carton)", "product_quantity": "506,080 vials", "reason_for_recall": "Lack of Assurance of Sterility: Media fill with bacterial contamination", "recall_initiation_date": "20250321", "center_classification_date": "20250408", "report_date": "20250416", "code_info": "NDC 70069-101-25; A240304, A240305, A240320, A240322, A240334, A240335, A240340, exp. date 05/2026;  A240342, A240347, A240385, A240391, exp. date 06/2026;   NDC 70069-101-05;  A240326, exp. date 05/2026"}, {"status": "Ongoing", "city": "Ledgewood", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "96329", "recalling_firm": "Imprimis NJOF, LLC", "address_1": "1705 Route 46 Ste 6B", "address_2": "", "postal_code": "07852-9720", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "", "distribution_pattern": "FL and NY", "recall_number": "D-0305-2025", "product_description": "Tropicamide - Proparacaine - Phenylephrine - Ketorolac Sterile Ophthalmic Solution, 1% 0.5%  2.5%  0.5%, 5 mL fill in 15 mL bottle, Imprimis NJOF, LLC, Route 46 West, Unit 6B, Ledgewood, NJ, 07852, NDC: 71384-733-05.", "product_quantity": "2822 bottles", "reason_for_recall": "Sub-Potent Drug: The stability batch showed a subpotent result, which does not meet the product specifications of 90.0-110.0% of the label claim.", "recall_initiation_date": "20250224", "center_classification_date": "20250328", "report_date": "20250409", "code_info": "Lot 24OCT041, Exp 04/26/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Panchmahal", "state": "N/A", "country": "India", "classification": "Class II", "openfda": {"application_number": ["ANDA210560"], "brand_name": ["BROMFENAC OPHTHALMIC SOLUTION 0.09%"], "generic_name": ["BROMFENAC OPHTHALMIC SOLUTION 0.09%"], "manufacturer_name": ["Alembic Pharmaceuticals Inc."], "product_ndc": ["62332-508"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["OPHTHALMIC"], "substance_name": ["BROMFENAC SODIUM"], "rxcui": ["578018"], "spl_id": ["824d37d0-e25f-4df8-be0e-d9a65046fc10"], "spl_set_id": ["225070ee-d862-4d41-84b8-5bd7a8a03fd7"], "package_ndc": ["62332-508-17"], "is_original_packager": [true], "unii": ["8ECV571Y37"]}, "product_type": "Drugs", "event_id": "96836", "recalling_firm": "Alembic Pharmaceuticals Limited", "address_1": "Formulation Division, Village Panelav, P.O. Tajpura, Near Baska, Taluka Halol", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "US Nationwide", "recall_number": "D-0447-2025", "product_description": "Bromfenac Ophthalmic Solution 0.09%, 1.7 mL bottle, Rx only, Sterile, Manufactured for: Alembic Pharmaceuticals, Inc., Bedminster, NJ 07921, USA, Manufactured by Alembic Pharmaceuticals Limitied, Gujarat, India, Made in India, NDC 62332-508-17", "product_quantity": "N/A", "reason_for_recall": "Failed Impurities/Degradation Specifications", "recall_initiation_date": "20250507", "center_classification_date": "20250527", "report_date": "20250604", "code_info": "Lot 7230309, Exp Date: 5/31/2025; Lot 7230310, Exp Date: 5/31/2025; Lot 7230311, Exp Date: 5/31/2025"}, {"status": "Ongoing", "city": "New Albany", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA090534"], "brand_name": ["NICARDIPINE HYDROCHLORIDE"], "generic_name": ["NICARDIPINE HYDROCHLORIDE"], "manufacturer_name": ["Civica, Inc."], "product_ndc": ["72572-470"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["NICARDIPINE HYDROCHLORIDE"], "rxcui": ["858607"], "spl_id": ["fba70df6-5d37-4a12-bce3-e6fb1b0c72b2"], "spl_set_id": ["30fb3a4d-fa75-42fd-b4b6-2a21f202027f"], "package_ndc": ["72572-470-01", "72572-470-10"], "is_original_packager": [true], "unii": ["K5BC5011K3"]}, "product_type": "Drugs", "event_id": "96695", "recalling_firm": "American Regent, Inc.", "address_1": "6610 New Albany Rd E", "address_2": "N/A", "postal_code": "43054-8730", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0398-2025", "product_description": "niCARdipine Hydrochloride Injection, USP, 25 mg/10 mL (2.5 mg/mL), 10 mL Single Dose Vial, Rx Only, Mfd for: Civica, Inc., Lehi, UT 84043,Mfd by: American Regent, Inc., New Albany, OH 43064. NDC Carton: 72572-470-10/ NDC Vial: 72572-470-01.", "product_quantity": "29,777 (cartons of 10 x 10mL vials)", "reason_for_recall": "Lack of sterility assurance: Product leakage around the vial neck, which could potentially result in a lack of sterility assurance.", "recall_initiation_date": "20250418", "center_classification_date": "20250501", "report_date": "20250507", "code_info": "Lots, expiry: Lot 24025N0C0, 6/30/2025; Lot 24115N0C0, 10/31/2025; Lot 24116N0C0, 3/31/2026; Lot 24160N0C0, 12/31/2025; Lot 24217N0C0, 01/31/2026; Lot 24288N0C0, 04/30/2026; Lot 24331N0C0, 5/31/2026", "more_code_info": ""}, {"status": "Ongoing", "city": "Smyrna", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["505G(a)(3)"], "brand_name": ["HAND SANITIZER"], "generic_name": ["ETHYL ALCOHOL"], "manufacturer_name": ["Medline Industries, LP"], "product_ndc": ["53329-202"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["ALCOHOL"], "rxcui": ["581662"], "spl_id": ["42c83824-c26a-787f-e063-6394a90aedd7"], "spl_set_id": ["f84f7050-348d-4f75-ab93-e618ff8de790"], "package_ndc": ["53329-202-13", "53329-202-04", "53329-202-08", "53329-202-70", "53329-202-84", "53329-202-85", "53329-202-74"], "is_original_packager": [true], "upc": ["0193489179739", "888277349455"], "unii": ["3K9958V90M"]}, "product_type": "Drugs", "event_id": "96960", "recalling_firm": "Consumer Product Partners, LLC", "address_1": "1 Swan Dr", "address_2": "N/A", "postal_code": "37167-2099", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0458-2025", "product_description": "Spectrum Advanced Gel Hand Sanitizer, Ethyl alcohol 70%, 8 FL OZ (236 mL) per bottle, Manufactured for Medline Industries, Inc., Three Lakes Drive, Northfield, IL 60693 USA.  NDC:  53329-202-08, UPC 8 88277 34945 5", "product_quantity": "125,040 bottles", "reason_for_recall": "Subpotent product: Product has cloudy appearance and tested below assay label claim for 70% Ethyl Alcohol", "recall_initiation_date": "20250523", "center_classification_date": "20250605", "report_date": "20250611", "code_info": "Lot, expiry: Lot 0644682, exp 2026/11/14; Lot 0644683, exp 2026/11/16"}, {"status": "Terminated", "city": "Irving", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96600", "recalling_firm": "Medisca Inc.", "address_1": "6641 N Belt Line Rd Ste 130", "address_2": "N/A", "postal_code": "75063-6001", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "N/A", "distribution_pattern": "US Nationwide.", "recall_number": "D-0386-2025", "product_description": "Bimatoprost powder, Bulk Ingredient, a) 5g (NDC 38779-3066-03), b) 1g (NDC 38779-3066-06), c) 1g (NDC 38779-3066-09) drums, Medisca, Plattsburgh, NY", "product_quantity": "161.6 grams", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20250331", "center_classification_date": "20250421", "termination_date": "20251010", "report_date": "20250430", "code_info": "Lot# 201727/A/B/C/D/E & F, exp.  date 05/31/2027, product # 3066 Lot# 208475/A/B/D/E/G/H & I, exp. date 09/30/2028, product # 3066"}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA077987"], "brand_name": ["PRAVASTATIN SODIUM"], "generic_name": ["PRAVASTATIN SODIUM"], "manufacturer_name": ["NorthStar RxLLC"], "product_ndc": ["16714-558", "16714-559", "16714-560", "16714-570"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["PRAVASTATIN SODIUM"], "rxcui": ["904458", "904467", "904475", "904481"], "spl_id": ["fa078b35-ee9d-4b9f-bb8d-e77949c09f88"], "spl_set_id": ["ce15ad07-3286-478f-9f30-1db6a45ed402"], "package_ndc": ["16714-558-01", "16714-558-02", "16714-559-01", "16714-559-02", "16714-560-01", "16714-560-02", "16714-570-01", "16714-570-02"], "is_original_packager": [true], "upc": ["0316714570013", "0316714559018", "0316714560014"], "unii": ["3M8608UQ61"]}, "product_type": "Drugs", "event_id": "96474", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0349-2025", "product_description": "Pravastatin Sodium Tablets, USP, 20mg, a).90-count bottle, Rx Only, Mfd for: Northstar Rx LLC, Memphis, TN 38141, Mfd by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh 454775, India. NDC# 16714-559-01", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20250313", "center_classification_date": "20250408", "report_date": "20250416", "code_info": "Lot #  17230810, exp. date Mar-26"}, {"status": "Ongoing", "city": "Unknown", "state": "N/A", "country": "China", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "96833", "recalling_firm": "EnShiShiXiangNiShangMaoYouXianGongSi", "address_1": "Unknown", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide Via Amazon Platform", "recall_number": "D-0453-2025", "product_description": "ENDURANCE BOOST WITH HORNY GOAT WEED, 500mg, 20 capsules per carton,  VEPEMVA Nutrition Supplement....rgy and Endurance, UPC X004BB9Z8N", "product_quantity": "600, 20-count cartons", "reason_for_recall": "Marketed without approved NDA/ANDA: The product has been found to be tainted with  Sildenafil and Propoxyphenylsildenafil (a sildenafil analogue).", "recall_initiation_date": "20250506", "center_classification_date": "20250529", "report_date": "20250604", "code_info": "Lot: 250214PRO, Expiration Date: 02/14/2027."}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA078251"], "brand_name": ["CARVEDILOL"], "generic_name": ["CARVEDILOL"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "product_ndc": ["68462-162", "68462-163", "68462-164", "68462-165"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CARVEDILOL"], "rxcui": ["200031", "200032", "200033", "686924"], "spl_id": ["5f5b2d20-cc2a-4e91-b2b9-260e7438ab2c"], "spl_set_id": ["c4a21f67-7812-4634-beba-f8e85c63c5f2"], "package_ndc": ["68462-162-60", "68462-162-01", "68462-162-18", "68462-162-05", "68462-162-10", "68462-163-60", "68462-163-01", "68462-163-18", "68462-163-05", "68462-163-10", "68462-164-60", "68462-164-01", "68462-164-18", "68462-164-05", "68462-164-10", "68462-165-60", "68462-165-01", "68462-165-18", "68462-165-05", "68462-165-10"], "is_original_packager": [true], "upc": ["0368462162019", "0368462163016", "0368462164013", "0368462165010"], "nui": ["N0000000099", "N0000009923", "N0000009924", "N0000175553", "N0000175556"], "pharm_class_moa": ["Adrenergic alpha-Antagonists [MoA]", "Adrenergic beta1-Antagonists [MoA]", "Adrenergic beta2-Antagonists [MoA]"], "pharm_class_epc": ["alpha-Adrenergic Blocker [EPC]", "beta-Adrenergic Blocker [EPC]"], "unii": ["0K47UL67F2"]}, "product_type": "Drugs", "event_id": "96474", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0336-2025", "product_description": "Carvedilol Tablets, USP 12.5 mg, 500-count bottle, Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh 454775, India, Manufactured for: Glenmark Pharmaceuticals Inc. USA, Mahwah, NJ 07430 NDC# 68462-164-05.", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20250313", "center_classification_date": "20250408", "report_date": "20250416", "code_info": "Lot #  17240238, exp. date  Jan-26  17240243, exp. date  Jan-26 17240245, exp. date  Jan-26  17240248, exp. date  Jan-26"}, {"status": "Ongoing", "city": "Columbus", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA209101"], "brand_name": ["HALOPERIDOL DECANOATE"], "generic_name": ["HALOPERIDOL DECANOATE"], "manufacturer_name": ["BluePoint Laboratories"], "product_ndc": ["68001-578", "68001-579", "68001-580", "68001-581", "68001-582"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR"], "substance_name": ["HALOPERIDOL DECANOATE"], "rxcui": ["859871", "1719803", "1719862"], "spl_id": ["048557ea-f859-f0f2-e063-6294a90af5ab"], "spl_set_id": ["f2d14406-2ad4-4c5b-9c24-a026f27b415d"], "package_ndc": ["68001-579-59", "68001-579-48", "68001-580-41", "68001-581-41", "68001-581-48", "68001-581-82", "68001-578-59", "68001-578-48", "68001-582-41"], "is_original_packager": [true], "upc": ["0368001578592", "0368001581417", "0368001579599", "0368001582414"], "unii": ["AC20PJ4101"]}, "product_type": "Drugs", "event_id": "96636", "recalling_firm": "Amerisource Health Services LLC", "address_1": "2550 John Glenn Ave Ste A", "address_2": "N/A", "postal_code": "43217-1188", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0369-2025", "product_description": "Haloperidol Decanoate Injection, 100mg/mL*, 5 x 1 mL Single-Dose Vials, Rx Only,  Manufactured by: Somerset Therapeutics Limited, #54/1 Boodhihal Village, Nelamangala, Bangalore -562123, Karnataka, India, Manufactured for: BluePoint Laboratories, NDC 68001-581-48.", "product_quantity": "143 1x5 vials", "reason_for_recall": "Lack of assurance of sterility. Bacterial contamination detected in some media fill units", "recall_initiation_date": "20250402", "center_classification_date": "20250418", "report_date": "20250430", "code_info": "A240482B, EXP 08/31/2026"}, {"status": "Ongoing", "city": "East Windsor", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA216379"], "brand_name": ["TIROFIBAN"], "generic_name": ["TIROFIBAN"], "manufacturer_name": ["Eugia US LLC"], "product_ndc": ["55150-429", "55150-430"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["TIROFIBAN HYDROCHLORIDE"], "rxcui": ["1737466", "1737471"], "spl_id": ["1751523a-e22e-4faf-bdb1-c850afe2fd36"], "spl_set_id": ["d554acff-22e9-4f28-b826-ee1b91daa2df"], "package_ndc": ["55150-429-01", "55150-430-01"], "is_original_packager": [true], "upc": ["0355150430017", "0355150429011"], "unii": ["6H925F8O5J"]}, "product_type": "Drugs", "event_id": "96718", "recalling_firm": "Eugia US LLC", "address_1": "279 Princeton Hightstown Rd", "address_2": "N/A", "postal_code": "08520-1401", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide.", "recall_number": "D-0389-2025", "product_description": "Tirofiban Hydrochloride Injection 5 mg/100 mL (50 mcg/mL), 100 mL single-dose container (bag), Rx only, Manufactured in India for: Eugia U.S. LLC, 279 Princeton-Hightstown Rd., E. Windsor, NJ 08520, NDC 55150-429-01", "product_quantity": "18,867 bags", "reason_for_recall": "Out-of-Specification test results were obtained in at long term conditions during 3 month's stability study for related substances.", "recall_initiation_date": "20250421", "center_classification_date": "20250425", "report_date": "20250507", "code_info": "Lot #: 3TF24002A, Exp 11/30/2026", "more_code_info": ""}, {"status": "Ongoing", "city": "Clark", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96390", "recalling_firm": "L'Oreal USA", "address_1": "222 Terminal Ave", "address_2": "", "postal_code": "07066-1317", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0419-2025", "product_description": "La Roche-Posay Laboratoire Dermatologique Effaclar Duo Dual Action Acne Treatment, 5.5% Benzoyl Peroxide Acne Medication, a) UPC 3606000508804, 20 mL (0.7 fl. oz.) Tube per Carton, b) 883140500759, 40 mL (1.35 fl. oz.) Tube per Carton, La Roche-Posay LLC, 10 Hudson Yards, New York, NY 10001, La Roche-Posay, France.", "product_quantity": "", "reason_for_recall": "cGMP Deviations: The recall was initiated due to detected trace levels of benzene in a specific lot of this product lot (MYX46W), however out of an abundance of caution, the firm voluntarily recalled all La Roche-Posay Effaclar Duo Dual Action Acne Treatment lots.", "recall_initiation_date": "20250305", "center_classification_date": "20250509", "report_date": "20250521", "code_info": "a) Lot #s, Expiration dates: MYX30W 03/2025 MYX43W 04/2025 MYX41W 04/2025 MYX42W 04/2025 MYX40W 04/2025 MYX51W 05/2025 MYX50W 05/2025 MYX60W 05/2025 MYX71W 06/2025 MYX90W 08/2025 MYX91W 09/2025 MYX92W 08/2025 MYXO0W 09/2025 MYX93W  09/2025 MYXD1W  11/2025 MYXD2W  11/2025 MYXDOW 09/2025 MYXD4W  11/2025 MYXD3W  11/2025 MYY22W  02/2026 MYY21W  02/2026 MYY20W  02/2026 MYY41W  04/2026 MYY40W  04/2026 MYY42W  04/2026 MYY43W  04/2026 MYY52W  05/2026 MYY51W  05/2026 MYY50W  05/2026 MYY60W  06/2026  b) Lot #s, Expiration dates MYX31W  3/2025  MYX32W  3/2025  MYX33W  3/2025  MYX34W  3/2025  MYX35W  3/2025  MYX40W  3/2025  MYX41W  4/2025  MYX42W  4/2025  MYX44W  4/2025  MYX45W  4/2025   MYX47W  4/2025  MYX48W  4/2025  MYX49W  4/2025  MYX50W  5/2025  MYX51W  5/2025  MYX52W  5/2025  MYX70W  6/2025  MYX71W  6/2025  MYX72W  7/2025  MYX73W  7/2025  MYX74W  7/2025  MYX75W  7/2025  MYX77W  7/2025  MYX78W  7/2025  MYX80W  8/2025  MYX81W  7/2025  MYX82W  8/2025  MYX83W  8/2025  MYX84W  7/2025  MYXO0W  9/2025  MYXO1W  8/2025  MYXO3W  8/2025  MYXO4W  9/2025  MYXO5W  9/2025  MYXO7W  9/2025  MYXO8W  8/2025  MYXO9W  9/2025  MYXD0W  11/2025  MYXD1W  12/2025  MYXD2W  11/2025  MYXD3W  11/2025  MYXD4W  11/2025  MYXD5W  11/2025  MYXD6W  12/2025  MYY22W  02/2026  MYY23W  02/2026  MYY30W  02/2026  MYY31W  03/2026  MYY32W  03/2026  MYY40W  03/2026  MYY41W  04/2026  MYY42W  04/2026  MYY43W  04/2026  MYY51W  04/2026  MYY60W  06/2026  MYY61W  06/2026  MYY62W  06/2026  MYY63W  06/2026  MYY64W    06/2026 MYY65W    06/2026 MYY66W    06/2026", "more_code_info": ""}, {"status": "Ongoing", "city": "Melville", "state": "NY", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "96290", "recalling_firm": "Ascent Consumer Products Inc.", "address_1": "105 Baylis Rd", "address_2": "N/A", "postal_code": "11747-3833", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the US.", "recall_number": "D-0301-2025", "product_description": "SinuCleanse Soft Tip NETI POT Nasal Wash System (sodium bicarbonate USP 700 mg and sodium chloride USP 2300 mg), 30-count All Natural USP Grade Saline Packets and 1 kettle style Neti Pot, Net WT 0.1OZ (3g) each, Distributed by Ascent Consumer Products Inc., Melville, NY 11747, UPC 6 46011 00102 7", "product_quantity": "unknown", "reason_for_recall": "Microbial Contamination of Non-Sterile Products: Bacterial contamination with Staphylococcus aureus", "recall_initiation_date": "20250128", "center_classification_date": "20250325", "report_date": "20250402", "code_info": "Lot# 024122661Al, Exp Date 12/2027"}, {"status": "Ongoing", "city": "Torrance", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96699", "recalling_firm": "Nubratori, Inc", "address_1": "381 Van Ness Ave Ste 1507", "address_2": "N/A", "postal_code": "90501-7220", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "PA and CA.", "recall_number": "D-0392-2025", "product_description": "Dexonto 0.4% (dexamethasone sodium phosphate) solution 20 mg/5 mL (4 mg/mL), Rx Only, 12 - 5 mL Single Dose Units per box, Preservative Free, For Iontophoresis Use Only, Non-Sterile Product, Not for Injection, NUBRATORI RX, 381 Van Ness Ave# 1507, CA 90501, NDC 71300-6564-1 (box), 71300-6564-3 (vial).", "product_quantity": "20 boxes", "reason_for_recall": "Labeling: Incorrect or Missing Lot and/or Expiration date: Individual vials of Dexonto 0.4%, are labeled correctly with the BUD of 12/25/2024, however, the outer box on some of the Dexonto 0.4% are labeled incorrectly with a BUD of 12/25/2025.", "recall_initiation_date": "20250415", "center_classification_date": "20250428", "report_date": "20250507", "code_info": "Lot #: C04292401X1, BUD: 12/25/2025 (box).", "more_code_info": ""}, {"status": "Ongoing", "city": "Saint Louis", "state": "MO", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M018"], "brand_name": ["CARBOXYMETHYLCELLULOSE SODIUM"], "generic_name": ["CARBOXYMETHYLCELLULOSE SODIUM"], "manufacturer_name": ["AvPAK"], "product_ndc": ["50268-066"], "product_type": ["HUMAN OTC DRUG"], "route": ["OPHTHALMIC"], "substance_name": ["CARBOXYMETHYLCELLULOSE SODIUM"], "rxcui": ["579907"], "spl_id": ["130364f2-4379-9324-e063-6294a90a9747"], "spl_set_id": ["b469f1c4-bd94-6f50-e053-2995a90a452f"], "package_ndc": ["50268-066-15"], "is_original_packager": [true], "unii": ["K679OBS311"]}, "product_type": "Drugs", "event_id": "96741", "recalling_firm": "BRS Analytical Services, LLC", "address_1": "11697 Lakeside Crossing Ct", "address_2": "N/A", "postal_code": "63146-8606", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0405-2025", "product_description": "Carboxymethylcellulose Sodium Ophthalmic Gel 1%, Carboxymethlycellulose Sodium 1% Eye Lubricant, Lubricant Eye Gel, Soothing Gel, Sterile, 0.5 FL OZ (15mL) per bottle, Distributed by: AvKARE, Pulaski, TN 38478, NDC: 50268-066-15.", "product_quantity": "1,610 cases (24 cartons per case)", "reason_for_recall": "cGMP deviations and lack of assurance of sterility.", "recall_initiation_date": "20250423", "center_classification_date": "20250506", "report_date": "20250514", "code_info": "Lot, expiry:  Lot 114, exp 9/04/25; Lot 115, exp 9/06/25; Lot 116, exp 9/10/25; Lot 207, exp 12/05/26", "more_code_info": ""}, {"status": "Ongoing", "city": "Hawthorne", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96508", "recalling_firm": "Alchemee, LLC", "address_1": "3 Skyline Dr", "address_2": "N/A", "postal_code": "10532-2174", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0360-2025", "product_description": "Proactiv Skin Smoothing Exfoliator (Benzoyl Peroxide 2.5%), Packaged as a) 6 fl. oz. (177.4 mL), UPC 7 35786 01528 2; b) 0.33 OZ (9.45g), UPC 8 42944 10223 1; Distributed by Alchemee, LLC, Santa Monica, CA 90401,", "product_quantity": "3,500 bottles", "reason_for_recall": "Chemical contamination: Presence of benzene", "recall_initiation_date": "20250312", "center_classification_date": "20250409", "report_date": "20250416", "code_info": "Lot, V4204A, Exp 07/31/2025"}, {"status": "Ongoing", "city": "Ta. Kadi, District Mehsana", "state": "N/A", "country": "India", "classification": "Class II", "openfda": {"application_number": ["M030"], "brand_name": ["KINGSKIN SACA CALLOS"], "generic_name": ["SALICYLIC ACID"], "manufacturer_name": ["Pharmadel LLC"], "product_ndc": ["55758-423"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["SALICYLIC ACID"], "rxcui": ["312881"], "spl_id": ["32ed3823-8328-609f-e063-6294a90a3fa8"], "spl_set_id": ["1d9fc86a-7e9b-4ea4-e063-6294a90a531c"], "package_ndc": ["55758-423-15"], "is_original_packager": [true], "unii": ["O414PZ4LPZ"], "upc": ["810096771636"]}, "product_type": "Drugs", "event_id": "96797", "recalling_firm": "KENIL HEALTHCARE PRIVATE LIMITED", "address_1": "Plot 319", "address_2": "Village Acharasan, Ankhol-Vamaj Road", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "DE and NC", "recall_number": "D-0424-2025", "product_description": "Kingskin, SacaCallos, 17% Salicylic acid, 0.5 fl oz (14.8mL) Bottle, Dist. by: Pharmadel LLC, New Castle, DE 19720, Made in India, NDC 55758-423-15, UPC 8 10096 77163 6.", "product_quantity": "9,000 Bottles", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20250424", "center_classification_date": "20250519", "report_date": "20250528", "code_info": "Lot SP28A, Exp Date: 09/30/2026"}, {"status": "Ongoing", "city": "Ta. Kadi, District Mehsana", "state": "N/A", "country": "India", "classification": "Class II", "openfda": {"application_number": ["M021"], "brand_name": ["NATURE MINT ANTICAVITY"], "generic_name": ["SODIUM MONOFLUOROPHOSPHATE"], "manufacturer_name": ["Bob Barker Company Inc."], "product_ndc": ["53247-131"], "product_type": ["HUMAN OTC DRUG"], "route": ["DENTAL"], "substance_name": ["SODIUM MONOFLUOROPHOSPHATE"], "rxcui": ["545626"], "spl_id": ["25cae217-37ed-403c-8a97-acfae13ef681"], "spl_set_id": ["39e9c844-d2c2-4e3c-84c0-bdb767a03f7b"], "package_ndc": ["53247-131-01", "53247-131-02", "53247-131-03", "53247-131-04", "53247-131-05", "53247-131-06", "53247-131-07"], "is_original_packager": [true], "unii": ["C810JCZ56Q"]}, "product_type": "Drugs", "event_id": "96797", "recalling_firm": "KENIL HEALTHCARE PRIVATE LIMITED", "address_1": "Plot 319", "address_2": "Village Acharasan, Ankhol-Vamaj Road", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "DE and NC", "recall_number": "D-0435-2025", "product_description": "Nature Mint, Anticavity Fluoride Toothpaste, Sodium monofluorophosphate 0.76%, NET WT 4.6 OZ (130 grams) Tube, Made in India, Dist. by Bob Barker Co. Inc., Fuquay-Varina, NC 27526, NDC 53247-131-06", "product_quantity": "19,500 Tubes", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20250424", "center_classification_date": "20250519", "report_date": "20250528", "code_info": "Lot B0027, B0031, Exp Date: 06/30/2026; Lot B0032, Exp Date: 07/31/2026"}, {"status": "Ongoing", "city": "Columbus", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA209101"], "brand_name": ["HALOPERIDOL DECANOATE"], "generic_name": ["HALOPERIDOL DECANOATE"], "manufacturer_name": ["BluePoint Laboratories"], "product_ndc": ["68001-578", "68001-579", "68001-580", "68001-581", "68001-582"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR"], "substance_name": ["HALOPERIDOL DECANOATE"], "rxcui": ["859871", "1719803", "1719862"], "spl_id": ["048557ea-f859-f0f2-e063-6294a90af5ab"], "spl_set_id": ["f2d14406-2ad4-4c5b-9c24-a026f27b415d"], "package_ndc": ["68001-579-59", "68001-579-48", "68001-580-41", "68001-581-41", "68001-581-48", "68001-581-82", "68001-578-59", "68001-578-48", "68001-582-41"], "is_original_packager": [true], "upc": ["0368001578592", "0368001581417", "0368001579599", "0368001582414"], "unii": ["AC20PJ4101"]}, "product_type": "Drugs", "event_id": "96636", "recalling_firm": "Amerisource Health Services LLC", "address_1": "2550 John Glenn Ave Ste A", "address_2": "N/A", "postal_code": "43217-1188", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0367-2025", "product_description": "Haloperidol Decanoate Injection, 50mg/mL* , 1 mL Single-Dose Vial, Rx only, Manufactured by Somerset Therapeutics Limited, 54/1, Boodhihal Village, Nelamangala, Bangalore - 562123, Karnataka, India, Manufactured for: BluePoint Laboratories, NDC 68001-580-41.", "product_quantity": "2,110 vials", "reason_for_recall": "Lack of assurance of sterility. Bacterial contamination detected in some media fill units", "recall_initiation_date": "20250402", "center_classification_date": "20250418", "report_date": "20250430", "code_info": "A240467B, EXP 07/31/2026"}, {"status": "Ongoing", "city": "Historic New Castle", "state": "DE", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M028"], "brand_name": ["KINGSKIN"], "generic_name": ["SALICYLIC ACID"], "manufacturer_name": ["Pharmadel LLC"], "product_ndc": ["55758-409"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["SALICYLIC ACID"], "rxcui": ["312881"], "spl_id": ["30de65a3-4991-e4d0-e063-6294a90a728c"], "spl_set_id": ["09974c86-6fba-3f20-e063-6294a90abd89"], "package_ndc": ["55758-409-15"], "is_original_packager": [true], "unii": ["O414PZ4LPZ"]}, "product_type": "Drugs", "event_id": "96639", "recalling_firm": "Pharmadel, LLC", "address_1": "650 Centerpoint Blvd", "address_2": "N/A", "postal_code": "19720-8108", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "DE", "recall_number": "D-0381-2025", "product_description": "Kingskin, Elimina Las Verrugas, For the removal of common warts, 0.50 oz fl (15 mL), Distributed by: Pharmadel, New Castle, DE 19720, NDC 55758-409-15", "product_quantity": "20,048 bottles", "reason_for_recall": "cGMP deviations", "recall_initiation_date": "20250415", "center_classification_date": "20250421", "report_date": "20250430", "code_info": "Lot, expiry: KSE-01, EXP: OCT 26; KSE-02, EXP: FEB 27"}, {"status": "Ongoing", "city": "Clark", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96390", "recalling_firm": "L'Oreal USA", "address_1": "222 Terminal Ave", "address_2": "", "postal_code": "07066-1317", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0418-2025", "product_description": "La Roche-Posay Laboratoire Dermatologique Effaclar Dermatological Acne System, 3 Step Acne Routine Kit, Medicated Gel Cleanser 3.4 fl. oz. (100 mL) Tube, Clarifying Solution 3.4 fl. oz. (100 mL) Tube, Dual Action Acne Treatment 0.7 fl. oz. (20 mL: UPC 883140035275) Tube, (benzoyl peroxide 0.5% and benzoyl peroxide 5.5% and salicylic acid 2%), La Roche-Posay LLC, 10 Hudson Yards, New York, NY 10001, La Roche-Posay, France, UPC 883140035282 (kit).", "product_quantity": "14,460 bottles", "reason_for_recall": "cGMP Deviations: The recall was initiated due to detected trace levels of benzene in a specific lot of this product lot (MYX46W), however out of an abundance of caution, the firm voluntarily recalled all La Roche-Posay Effaclar Duo Dual Action Acne Treatment lots.", "recall_initiation_date": "20250305", "center_classification_date": "20250509", "report_date": "20250521", "code_info": "Lot #s, Expiration Dates: MYX30W, Exp 03/31/2025 MYX32W, Exp 03/31/2025 MYX33W, Exp 03/31/2025 MYX41W, Exp 04/30/2025 MYX42W, Exp 04/30/2025 MYX43W, Exp 04/30/2025 MYX44W, Exp 04/30/2025 MYX45W, Exp 04/30/2025 MYX50W, Exp 05/31/2025 MYX51W, Exp 04/30/2025 MYX52W, Exp 04/30/2025 MYX53W, Exp 05/31/2025 MYX70W, Exp 07/31/2025 MYX80W, Exp 07/31/2025 MYX81W, Exp 07/31/2025 MYX90W, Exp 08/31/2025 MYX91W, Exp 08/31/2025 MYX92W, Exp 08/31/2025 MYX93W, Exp 08/31/2025 MYXD0W, Exp 09/30/2025 MYXO1W, Exp 09/30/2025 MYXO2W, Exp 09/30/2025 MYXO3W, Exp 09/30/2025 MYXO4W, Exp 09/30/2025 MYXO5W, Exp 09/30/2025 MYY21W, Exp 02/28/2026 MYY23W, Exp 02/28/2026 MYY26W, Exp 02/28/2026 MYY27W, Exp 02/28/2026 MYY31W, Exp 03/31/2026 MYY32W, Exp 11/30/2025 MYY33W, Exp 11/30/2025 MYY34W, Exp 03/31/2026 MYY50W, Exp 05/31/2026 MYY51W, Exp 05/31/2026 MYY60W, Exp 05/31/2026 MYY61W, Exp 03/31/2026 MYY62W, Exp 06/30/2026 MYY63W, Exp 06/30/2026 MYY64W, Exp 06/30/2026 MYY72W, Exp 06/30/2026 MYY73W, Exp 06/30/2026 MYY74W, Exp 06/30/2026 MYY75W, Exp 06/30/2026 MYY76W, Exp 06/30/2026.", "more_code_info": ""}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA205268"], "brand_name": ["PROPAFENONE HYDROCHLORIDE"], "generic_name": ["PROPAFENONE HYDROCHLORIDE"], "manufacturer_name": ["Northstar Rx LLC"], "product_ndc": ["16714-825", "16714-826", "16714-827"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["PROPAFENONE HYDROCHLORIDE"], "rxcui": ["861156", "861164", "861171"], "spl_id": ["59aaf0aa-9074-4563-93ba-1c97e76352a2"], "spl_set_id": ["2ecd6452-ccc3-493f-9a4a-69f0fbf67a42"], "package_ndc": ["16714-825-01", "16714-826-01", "16714-827-01"], "is_original_packager": [true], "upc": ["0316714826011", "0316714827018", "0316714825014"], "unii": ["33XCH0HOCD"]}, "product_type": "Drugs", "event_id": "96474", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0351-2025", "product_description": "Propafenone Hydrochloride Extended-Release Capsules USP, 225mg 60-count bottles, Rx Only, Mfd by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh 454775, India. NDC# 16714-825-01.", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20250313", "center_classification_date": "20250408", "report_date": "20250416", "code_info": "Lot #  17230819, exp. date Mar-25"}, {"status": "Ongoing", "city": "Bengaluru", "state": "N/A", "country": "India", "classification": "Class II", "openfda": {"application_number": ["ANDA209101"], "brand_name": ["HALOPERIDOL DECANOATE"], "generic_name": ["HALOPERIDOL DECANOATE"], "manufacturer_name": ["Somerset Therapeutics, LLC"], "product_ndc": ["70069-030", "70069-031", "70069-381", "70069-382", "70069-383", "70069-384"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR"], "substance_name": ["HALOPERIDOL DECANOATE"], "rxcui": ["859867", "859871", "1719803", "1719862"], "spl_id": ["f6d888a0-65a7-4073-8671-b00b4bfaff4c"], "spl_set_id": ["f2bff27f-929f-4f7d-b3eb-084ebc2a885f"], "package_ndc": ["70069-030-05", "70069-030-03", "70069-031-01", "70069-031-05", "70069-381-01", "70069-381-10", "70069-382-01", "70069-382-05", "70069-383-05", "70069-383-10", "70069-383-01", "70069-384-01", "70069-384-05"], "is_original_packager": [true], "upc": ["0370069382011", "0370069383018", "0370069031018", "0370069030011", "0370069384015"], "unii": ["AC20PJ4101"]}, "product_type": "Drugs", "event_id": "96569", "recalling_firm": "Somerset Therapeutics Private Limited", "address_1": "54/1 Budihal Village", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0358-2025", "product_description": "Haloperidol Decanoate Injection, 100 mg/mL, 1mL Single-Dose Vial, Rx Only, Manufactured for: Somerset Therapeutics, LLC, Somerset, NJ 08873, NDC 70069-383-10", "product_quantity": "240 vials", "reason_for_recall": "Lack of Assurance of Sterility: Media fill with bacterial contamination", "recall_initiation_date": "20250321", "center_classification_date": "20250408", "report_date": "20250416", "code_info": "A240482D, exp. date 08/2026"}, {"status": "Ongoing", "city": "Historic New Castle", "state": "DE", "country": "United States", "classification": "Class II", "openfda": {"brand_name": ["RAPIDOL ARNICA"], "generic_name": ["ARNICA MONTANA"], "manufacturer_name": ["Pharmadel LLC"], "product_ndc": ["55758-403"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["ARNICA MONTANA WHOLE"], "spl_id": ["0517e283-81da-5b52-e063-6294a90a4eaf"], "spl_set_id": ["0517e283-81d9-5b52-e063-6294a90a4eaf"], "package_ndc": ["55758-403-02"], "is_original_packager": [true], "unii": ["O80TY208ZW"]}, "product_type": "Drugs", "event_id": "96639", "recalling_firm": "Pharmadel, LLC", "address_1": "650 Centerpoint Blvd", "address_2": "N/A", "postal_code": "19720-8108", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "DE", "recall_number": "D-0382-2025", "product_description": "Rapidol Arnica Gel, Topical Gel, Homeopathic Medicine, 2 oz (57 g), Distributed by: Pharmadel, New Castle, DE 19720, NDC 55758-403-02", "product_quantity": "6,048 bottles", "reason_for_recall": "cGMP deviations", "recall_initiation_date": "20250415", "center_classification_date": "20250421", "report_date": "20250430", "code_info": "Lot, expiry: EAG-01, EXP: MAR 27"}, {"status": "Ongoing", "city": "Historic New Castle", "state": "DE", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96639", "recalling_firm": "Pharmadel, LLC", "address_1": "650 Centerpoint Blvd", "address_2": "N/A", "postal_code": "19720-8108", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "DE", "recall_number": "D-0380-2025", "product_description": "DoloEar Earache Drops, Homeopathic, 0.50 oz fl (15 mL), Distributed by: Pharmadel, New Castle, DE 19720, NDC 55758-401-15", "product_quantity": "27,648 bottles", "reason_for_recall": "cGMP deviations", "recall_initiation_date": "20250415", "center_classification_date": "20250421", "report_date": "20250430", "code_info": "Lot, expiry: DEE-01, EXP: OCT 26;  DEE-02 EXP: FEB 27"}, {"status": "Ongoing", "city": "Fayetteville", "state": "AR", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "96706", "recalling_firm": "OurPharma LLC", "address_1": "2512 S City Lake Rd", "address_2": "N/A", "postal_code": "72701-5013", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0385-2025", "product_description": "HYDROmorphone Hydrochloride 50mg/50mL (1mg/mL), packaged in a 50 mL Cassette, Rx Only, OurPharma, LLC, 2512 S. City Lake Rd., Fayetteville, AR 72701,  NDC 73013-1040-01.", "product_quantity": "1,375 cassettes", "reason_for_recall": "Superpotent Drug: Assay/potency result for hydromorphone HCl in the compounded stability lot was higher than specification..", "recall_initiation_date": "20250415", "center_classification_date": "20250421", "report_date": "20250430", "code_info": "104024120001, Exp Date 06/01/2025; 104024120002, Exp Date 06/21/2025; 104025010001, Exp Date 07/13/2025; 104025010002, Exp Date 07/28/2025"}]